These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
þ
|
Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
For the Fiscal Year Ended December 31, 2018
|
|
|
|
|
¨
|
Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
For the Transition Period from to
|
|
|
Rimini Street, Inc.
|
|
|
|
(Exact Name of Company as Specified in its Charter)
|
|
|
Delaware
|
|
36-4880301
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
3993 Howard Hughes Parkway, Suite 500,
Las Vegas, NV
|
|
89169
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
|
|
Registrant's telephone number, including area code:
|
|
(702) 839-9671
|
|
Title of each class:
|
|
Name of each exchange on which registered:
|
|
|
|
|
|
Common Stock, par value $0.0001 per share
|
|
The Nasdaq Global Market
|
|
|
|
|
|
Public Units, each consisting of one share of Common
|
|
|
|
Stock, $0.0001 par value, and one-half of one Warrant
|
|
OTC Pink Current Information Marketplace
|
|
|
|
|
|
Warrants, exercisable for one share of Common Stock, $0.0001 par value
|
|
OTC Pink Current Information Marketplace
|
|
Large accelerated filer
¨
|
Accelerated filer
þ
|
Non-accelerated filer
¨
|
|
Smaller reporting company
¨
|
|
Emerging growth company
þ
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
•
|
the evolution of the enterprise software support landscape facing our customers and prospects;
|
|
•
|
our ability to educate the market regarding the advantages of our enterprise software support services and products;
|
|
•
|
estimates of our total addressable market;
|
|
•
|
projections of customer savings;
|
|
•
|
our ability to maintain an adequate rate of revenue growth;
|
|
•
|
our expectations about future financial, operating and cash flow results;
|
|
•
|
the sufficiency of future cash and cash equivalents to meet our liquidity requirements;
|
|
•
|
our business plan and our ability to effectively manage our growth and associated investments;
|
|
•
|
beliefs and objectives for future operations;
|
|
•
|
our ability to expand our leadership position in independent enterprise software support;
|
|
•
|
our ability to attract and retain customers;
|
|
•
|
our ability to further penetrate our existing customer base;
|
|
•
|
our ability to maintain our competitive technological advantages against new entrants in our industry;
|
|
•
|
our ability to timely and effectively scale and adapt our existing technology;
|
|
•
|
our ability to innovate new products and bring them to market in a timely manner, including our recently announced salesforce.com offerings;
|
|
•
|
our ability to maintain, protect, and enhance our brand and intellectual property;
|
|
•
|
our ability to capitalize on changing market conditions including a market shift to hybrid and cloud/SaaS offerings for information technology environments;
|
|
•
|
our ability to develop strategic partnerships;
|
|
•
|
benefits associated with the use of our services;
|
|
•
|
our ability to expand internationally;
|
|
•
|
our ability to raise equity or debt financing in the future;
|
|
•
|
the effects of increased competition in our market and our ability to compete effectively;
|
|
•
|
our intentions with respect to our pricing model;
|
|
•
|
cost of revenues, including changes in costs associated with production, manufacturing and customer support;
|
|
•
|
operating expenses, including changes in sales and marketing and general administrative expenses;
|
|
•
|
anticipated income tax rates;
|
|
•
|
sufficiency of cash to meet cash needs for at least the next 12 months, including quarterly cash dividends payable on the Series A Preferred Stock;
|
|
•
|
our ability to maintain our good standing with the United States and international governments and capture new contracts;
|
|
•
|
costs associated with defending intellectual property infringement and other claims, such as those claims discussed in the section titled “
Business—Legal Proceedings
”;
|
|
•
|
the final amount and timing of any refunds from Oracle related to our litigation;
|
|
•
|
our expectations concerning relationships with third parties, including channel partners and logistics providers;
|
|
•
|
economic and industry trends or trend analysis;
|
|
•
|
the attraction and retention of qualified employees and key personnel;
|
|
•
|
future acquisitions of or investments in complementary companies, products, subscriptions or technologies;
|
|
•
|
the effects of seasonal trends on our results of operations, and
|
|
•
|
other risks and uncertainties, including those discussed under "Risk Factors" in Part 1, Item 1A of this Report.
|
|
Base Software Support Feature
|
|
Rimini Street
|
|
Typical Enterprise Software Vendor
|
|
|
Significant Annual Cost Savings Compared to the Software Vendor
|
|
•
|
|
|
|
|
Guaranteed 15 Minutes Response 24x7 For High Priority Issues
|
|
•
|
|
|
|
|
Named Primary Support Engineer for Each Client
|
|
•
|
|
|
|
|
Issue Resolution and Software Bug Fixes
|
|
•
|
|
•
|
|
|
Support for Application Customizations
|
|
•
|
|
|
|
|
Operational, Installation, Configuration and Upgrade Support
|
|
•
|
|
•
|
|
|
Migration Support
|
|
•
|
|
|
|
|
Performance, Interoperability and Integration Support
|
|
•
|
|
|
|
|
Security Support
|
|
•
|
|
|
|
|
Localization Support
|
|
•
|
|
|
|
|
New Features, Functions and Technical Releases
|
|
•
|
|
|
|
|
Tax, Legal and Regulatory Updates
|
|
•
|
|
•
|
|
|
Supported Vendor and Product Family
|
|
Supported Product Lines
|
|
IBM DB2 Database
|
|
All
|
|
Microsoft SQL Server Database
|
|
All
|
|
Oracle Siebel
|
|
All
|
|
Oracle PeopleSoft
|
|
HCM, FIN, CRM, EPM, SRM, SCM, Public Sector, and Campus Solutions
|
|
Oracle J.D. Edwards
|
|
HCM, Financials, Distribution and Manufacturing (World and EnterpriseOne)
|
|
Oracle E-Business Suite
|
|
All
|
|
Oracle Retail
|
|
Retek Merchandising Operations Management (MOM), Merchandise Planning & Optimization, Supply Chain Planning and Execution
|
|
Oracle Database
|
|
All
|
|
Oracle Fusion Middleware
|
|
All
|
|
Oracle Hyperion
|
|
Hyperion Planning, Essbase, Financial Management, Financial Close Management, Strategic Finance and Financial Management Analytics
|
|
Salesforce
|
|
Salesforce Sales Cloud and Salesforce Service Cloud
|
|
SAP Business Suite
|
|
R/3, ECC
|
|
SAP S/4HANA
|
|
All
|
|
SAP HANA Database
|
|
All
|
|
SAP Sybase Database
|
|
SAP ASE, SAP Advantage Server, SAP IQ, SAP SQL Anywhere
|
|
SAP Business Objects
|
|
Business Objects Enterprise, Advanced Analysis, Interactive Analysis (Web Intelligence), Explorer, Dashboard Design (Xcelsius) and Crystal Reports
|
|
Oracle Agile
|
|
All
|
|
Oracle ATG Web Commerce
|
|
Campaign Optimizer, Outreach, MDEX Engine 6.5, Oracle Commerce Guided Search (Endeca Search) and Experience Manager
|
|
•
|
use of our website to provide application and company information, as well as learning opportunities for potential customers;
|
|
•
|
business development representatives who respond to incoming leads to convert them into new sales opportunities;
|
|
•
|
participation in, and sponsorship of, field marketing events including user conferences, trade shows and industry events;
|
|
•
|
online marketing activities including email campaigns, online advertising and webinars;
|
|
•
|
public relations; and
|
|
•
|
thought leadership through marketing to industry analysts, webinars, speaking engagements and sponsored research.
|
|
•
|
track record of technical capability to provide the required software support;
|
|
•
|
ability to identify, develop and deliver required tax, legal and regulatory updates;
|
|
•
|
infrastructure model to deliver support globally within guaranteed service levels;
|
|
•
|
track record of providing a high level of client satisfaction;
|
|
•
|
ease of support model onboarding, deployment and usage;
|
|
•
|
breadth and depth of support functionality, including the ability to support customized software;
|
|
•
|
cost of products and services;
|
|
•
|
brand awareness and reputation;
|
|
•
|
capability for delivering services in a secure, scalable and reliable manner;
|
|
•
|
ability to innovate and respond to client needs rapidly; and
|
|
•
|
size of referenceable client base.
|
|
Name
|
|
Age
|
|
Position
|
|
Executive Officers
|
|
|
|
|
|
Seth A. Ravin
|
|
52
|
|
Chief Executive Officer and Chairman of the Board of Directors
|
|
Anthony DeShazor
|
|
46
|
|
Senior Vice President and Chief Client Officer
|
|
Sebastian Grady
|
|
55
|
|
President
|
|
Nancy Lyskawa
|
|
56
|
|
Senior Vice President, Global Client Onboarding
|
|
Kevin Maddock
|
|
53
|
|
Senior Vice President, Global Sales - Recurring Revenue
|
|
Julie Murphy
|
|
59
|
|
Senior Vice President and Chief People Officer
|
|
Jim Petraglia
|
|
62
|
|
Senior Vice President, Global Operations
|
|
David Rowe
|
|
53
|
|
Senior Vice President and Chief Marketing Officer
|
|
Thomas Sabol
|
|
60
|
|
Senior Vice President and Chief Financial Officer
|
|
Steven Salaets
|
|
41
|
|
Senior Vice President Global Security & Compliance and Chief Information Officer
|
|
Brian Slepko
|
|
55
|
|
Senior Vice President, Global Service Delivery
|
|
Daniel B. Winslow
|
|
60
|
|
Senior Vice President and General Counsel
|
|
•
|
price our products and services effectively so that we are able to attract new clients and retain existing clients without compromising our profitability;
|
|
•
|
introduce our products and services to new geographic markets;
|
|
•
|
introduce new enterprise software products and services supporting additional enterprise software vendors, products and releases;
|
|
•
|
satisfactorily conclude the Oracle litigation and any other litigation that may occur and our governmental inquiry; and
|
|
•
|
increase awareness of our company, products and services on a global basis.
|
|
•
|
sales and marketing efforts;
|
|
•
|
training to optimize our opportunities to overcome litigation risk concerns of our clients;
|
|
•
|
expanding in new geographical areas;
|
|
•
|
growing our product and service offerings and related capabilities;
|
|
•
|
adding additional product and service offerings; and
|
|
•
|
general administration, including legal and accounting expenses related to being a public company.
|
|
•
|
maintain our operations;
|
|
•
|
develop or enhance our products and services;
|
|
•
|
continue to expand our sales and marketing functions;
|
|
•
|
devote resources to research and development activities;
|
|
•
|
acquire complementary technologies, products or businesses;
|
|
•
|
expand operations, in the United States or globally;
|
|
•
|
hire, train and retain employees; or
|
|
•
|
respond to competitive pressures or unanticipated working capital requirements.
|
|
•
|
changes in spending on enterprise software products and services by our current or prospective clients;
|
|
•
|
pricing of our products and services so that we are able to attract and retain clients;
|
|
•
|
acquisition of new clients and increases of our existing clients’ use of our products and services;
|
|
•
|
client renewal rates and the amounts for which agreements are renewed;
|
|
•
|
budgeting cycles of our clients;
|
|
•
|
changes in the competitive dynamics of our market, including consolidation among competitors or clients;
|
|
•
|
the amount and timing of payment for operating expenses, particularly sales and marketing expenses and employee benefit expenses, as well as the quarterly Cash Dividends required to be made on our Series A Preferred Stock;
|
|
•
|
the amount and timing of non-cash expenses, including stock-based compensation, in-kind dividends on our Series A Preferred Stock and other non-cash charges;
|
|
•
|
the amount and timing of costs associated with recruiting, training and integrating new employees;
|
|
•
|
the amount and timing of cash collections from our clients;
|
|
•
|
unforeseen costs and expenses related to the expansion of our business, operations and infrastructure;
|
|
•
|
the amount and timing of our legal costs, particularly related to our litigation with Oracle;
|
|
•
|
changes in the levels of our capital expenditures; foreign currency exchange rate fluctuations; and
|
|
•
|
general economic and political conditions in our global markets.
|
|
•
|
changes in a specific country’s or region’s political or economic conditions;
|
|
•
|
changes in regulatory requirements, taxes or trade laws such as Brexit;
|
|
•
|
more stringent regulations relating to data security, such as where and how data can be housed, accessed and used, and the unauthorized use of, or access to, commercial and personal information;
|
|
•
|
differing labor regulations, especially in countries and geographies where labor laws are generally more advantageous to employees as compared to the United States, including deemed hourly wage and overtime regulations in these locations;
|
|
•
|
challenges inherent in efficiently managing an increased number of employees over large geographic distances, including the need to implement appropriate systems, policies, benefits and compliance programs as well as hire and retain local management, sales, marketing and support personnel;
|
|
•
|
difficulties in managing a business in new markets with diverse cultures, languages, customs, legal systems, alternative dispute systems and regulatory systems;
|
|
•
|
increased travel, real estate, infrastructure and legal compliance costs associated with global operations;
|
|
•
|
currency exchange rate fluctuations and the resulting effect on our revenue and expenses, and the cost and risk of entering into hedging transactions if we choose to do so in the future;
|
|
•
|
limitations on our ability to reinvest earnings from operations in one country to fund the capital needs of our operations in other countries;
|
|
•
|
laws and business practices favoring local competitors or general preferences for local vendors;
|
|
•
|
limited or insufficient intellectual property protection;
|
|
•
|
political instability or terrorist activities;
|
|
•
|
exposure to liabilities under anti-corruption and anti-money laundering laws, including the U.S. Foreign Corrupt Practices Act and similar laws and regulations in other jurisdictions; and
|
|
•
|
adverse tax burdens and foreign exchange controls that could make it difficult to repatriate earnings and cash.
|
|
•
|
inadequate controls in relation to recognition of liabilities for embedded derivatives in connection with our former Credit Facility (2016);
|
|
•
|
inadequate controls in relation to revenue recognition from support service sales contracts whereby RSI incorrectly accounted for multi-year, non-cancellable support service sales contracts as a single delivery arrangement and incorrectly accounting for revenue for certain non-standard contract provisions (2015 and 2016);
|
|
•
|
various sales tax control matters related to manual processes and determination of tax liabilities in certain states (2015); and
|
|
•
|
inadequate controls for accrual of loss contingencies related to RSI’s litigation with Oracle (2015).
|
|
•
|
developments in our continuing litigation with Oracle;
|
|
•
|
actions that may be taken by our holders of Series A Preferred Stock and the Convertible Notes;
|
|
•
|
any future equity or debt financing by us;
|
|
•
|
our ability to pay cash dividends payable on our Series A Preferred Stock or to effectively service any outstanding debt obligations;
|
|
•
|
the announcement of new products or product enhancements by us or our competitors;
|
|
•
|
developments concerning intellectual property rights;
|
|
•
|
changes in legal, regulatory and enforcement frameworks impacting our products;
|
|
•
|
developments in the governmental inquiry instituted in March 2018 and any legal proceedings instituted involving us, if any, from such inquiry;
|
|
•
|
variations in our and our competitors’ results of operations;
|
|
•
|
the addition or departure of key personnel;
|
|
•
|
announcements by us or our competitors of acquisitions, investments or strategic alliances;
|
|
•
|
actual or anticipated fluctuations in our quarterly and annual results and those of other public companies in our industry
|
|
•
|
the level and changes in our year-over-year revenue growth rate;
|
|
•
|
the failure of securities analysts to publish research about us, or shortfalls in our results of operations compared to levels forecast by securities analysts;
|
|
•
|
any delisting of our Common Stock from Nasdaq Global Market (“Nasdaq”) due to any failure to meet listing requirements;
|
|
•
|
our Public Warrants and units are quoted on the OTC Pink Current Information Marketplace which is a significantly more limited market than Nasdaq; and
|
|
•
|
the general state of the securities market.
|
|
•
|
a classified Board of Directors with three-year staggered terms, which could delay the ability of stockholders to change the membership of a majority of our Board of Directors;
|
|
•
|
the ability of our Board of Directors to issue shares of preferred stock, including “blank check” preferred stock, and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder
|
|
•
|
the limitation of the liability of, and the indemnification of our directors and officers;
|
|
•
|
the exclusive right of our Board of Directors to elect a director to fill a vacancy created by the expansion of the Board of Directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our Board of Directors;
|
|
•
|
the requirement that directors may only be removed from our Board of Directors for cause;
|
|
•
|
a prohibition on common stockholder action by written consent, which forces common stockholder action to be taken at an annual or special meeting of stockholders and could delay the ability of stockholders to force consideration of a stockholder proposal or to take action, including the removal of directors;
|
|
•
|
the requirement that a special meeting of stockholders may be called only by our Board of Directors, the chairperson of our Board of Directors, our chief executive officer or our president (in the absence of a chief executive officer), which could delay the ability of stockholders to force consideration of a proposal or to take action, including the removal of directors;
|
|
•
|
controlling the procedures for the conduct and scheduling of Board of Directors and stockholder meetings;
|
|
•
|
the requirement for the affirmative vote of holders of at least 66 2/3% of the voting power of all of the then outstanding shares of the voting stock, voting together as a single class, to amend, alter, change or repeal any provision of our certificate of incorporation or our bylaws, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in our Board of Directors and also may inhibit the ability of an acquirer to effect such amendments to facilitate an unsolicited takeover attempt;
|
|
•
|
the ability of our Board of Directors to amend the bylaws, which may allow our Board of Directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt; and
|
|
•
|
advance notice procedures with which stockholders must comply to nominate candidates to our Board of Directors or to propose matters to be acted upon at a stockholders’ meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in our Board of Directors and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of our company.
|
|
•
|
any derivative action or proceeding brought on behalf of us;
|
|
•
|
any action asserting a claim of breach of a fiduciary duty owed to us or our stockholders by any of our directors, officers or other employees;
|
|
•
|
any action asserting a claim against us or any of our directors, officers or employees arising out of or relating to any provision of the DGCL, our certificate of incorporation or our bylaws; or
|
|
•
|
any action asserting a claim against us or any of our directors, officers, stockholders or employees that is governed by the internal affairs doctrine of the Court of Chancery.
|
|
|
10/11/2017
|
12/31/2017
|
3/31/2018
|
6/30/2018
|
9/30/2018
|
12/31/2018
|
|
Rimini Street, Inc.
|
$100.00
|
$81.31
|
$88.07
|
$67.16
|
$64.66
|
$52.59
|
|
Nasdaq Composite Index
|
$100.00
|
$103.80
|
$105.96
|
$112.73
|
$120.85
|
$99.48
|
|
Dow Jones U.S. Computer Services Index
|
$100.00
|
$101.53
|
$107.04
|
$103.44
|
$112.45
|
$87.21
|
|
|
As of December 31,
|
||||||||||||||||||
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
|
Consolidated balance sheets data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cash, cash equivalents and restricted cash
|
$
|
25,206
|
|
|
$
|
40,027
|
|
|
$
|
28,237
|
|
|
$
|
12,559
|
|
|
$
|
13,860
|
|
|
Total assets
|
118,885
|
|
|
122,171
|
|
|
99,378
|
|
|
62,741
|
|
|
52,336
|
|
|||||
|
Long-term debt:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Current maturities of long-term debt
|
2,372
|
|
|
15,500
|
|
|
24,750
|
|
|
14,814
|
|
|
15,132
|
|
|||||
|
Long-term debt, net of current maturities
|
—
|
|
|
66,613
|
|
|
63,314
|
|
|
—
|
|
|
114
|
|
|||||
|
Total liabilities
|
270,473
|
|
|
332,472
|
|
|
312,888
|
|
|
275,060
|
|
|
221,541
|
|
|||||
|
Redeemable Series A Preferred Stock, net of discount
|
113,998
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Stockholders' deficit
|
(265,586
|
)
|
|
(210,301
|
)
|
|
(213,510
|
)
|
|
(212,319
|
)
|
|
(169,205
|
)
|
|||||
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
|
Consolidated statements of operations data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Revenue
|
$
|
252,790
|
|
|
$
|
212,633
|
|
|
$
|
160,175
|
|
|
$
|
118,163
|
|
|
$
|
85,348
|
|
|
Cost of revenue
|
95,981
|
|
|
82,898
|
|
|
67,045
|
|
|
52,766
|
|
|
45,258
|
|
|||||
|
Gross profit
|
156,809
|
|
|
129,735
|
|
|
93,130
|
|
|
65,397
|
|
|
40,090
|
|
|||||
|
Gross margin
(1)
|
62.0
|
%
|
|
61.0
|
%
|
|
58.1
|
%
|
|
55.3
|
%
|
|
47.0
|
%
|
|||||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Sales and marketing
|
93,215
|
|
|
66,759
|
|
|
72,936
|
|
|
50,330
|
|
|
37,509
|
|
|||||
|
General and administrative
|
36,982
|
|
|
36,144
|
|
|
36,212
|
|
|
24,220
|
|
|
19,270
|
|
|||||
|
Litigation costs and related recoveries, net
|
1,258
|
|
|
4,860
|
|
|
(29,949
|
)
|
|
32,732
|
|
|
103,266
|
|
|||||
|
Write-off of deferred offering costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,307
|
|
|||||
|
Total operating expenses
|
131,455
|
|
|
107,763
|
|
|
79,199
|
|
|
107,282
|
|
|
165,352
|
|
|||||
|
Operating income (loss)
|
25,354
|
|
|
21,972
|
|
|
13,931
|
|
|
(41,885
|
)
|
|
(125,262
|
)
|
|||||
|
Interest expense
|
(32,530
|
)
|
|
(43,357
|
)
|
|
(13,356
|
)
|
|
(829
|
)
|
|
(742
|
)
|
|||||
|
Other debt financing expenses
|
(58,331
|
)
|
|
(18,361
|
)
|
|
(6,372
|
)
|
|
—
|
|
|
—
|
|
|||||
|
Gain (loss) from change in fair value of redeemable warrants
|
—
|
|
|
(16,352
|
)
|
|
1,578
|
|
|
—
|
|
|
—
|
|
|||||
|
Gain (loss) from change in fair value of embedded derivatives
|
1,600
|
|
|
3,800
|
|
|
(5,400
|
)
|
|
—
|
|
|
—
|
|
|||||
|
Other income (expense), net
|
(2,066
|
)
|
|
320
|
|
|
(1,786
|
)
|
|
(1,104
|
)
|
|
(843
|
)
|
|||||
|
Loss before income taxes
|
(65,973
|
)
|
|
(51,978
|
)
|
|
(11,405
|
)
|
|
(43,818
|
)
|
|
(126,847
|
)
|
|||||
|
Income tax expense
|
(1,992
|
)
|
|
(1,319
|
)
|
|
(1,532
|
)
|
|
(1,451
|
)
|
|
(981
|
)
|
|||||
|
Net loss
|
$
|
(67,965
|
)
|
|
$
|
(53,297
|
)
|
|
$
|
(12,937
|
)
|
|
$
|
(45,269
|
)
|
|
$
|
(127,828
|
)
|
|
Net loss attributable to common stockholders
|
$
|
(78,606
|
)
|
|
$
|
(53,297
|
)
|
|
$
|
(22,937
|
)
|
|
$
|
(45,269
|
)
|
|
$
|
(127,828
|
)
|
|
Net loss per share attributable to common stockholders, basic and diluted
(2)
:
|
$
|
(1.28
|
)
|
|
$
|
(1.65
|
)
|
|
$
|
(0.95
|
)
|
|
$
|
(1.87
|
)
|
|
$
|
(5.29
|
)
|
|
Weighted average number of shares of Common Stock outstanding, basic and diluted
(2)
|
61,384
|
|
|
32,229
|
|
|
24,262
|
|
|
24,222
|
|
|
24,164
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Consolidated statements of cash flows data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net cash provided by (used in):
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Operating activities
|
$
|
22,382
|
|
|
$
|
29,163
|
|
|
$
|
(59,609
|
)
|
|
$
|
1,573
|
|
|
$
|
3,215
|
|
|
Investing activities
|
(1,053
|
)
|
|
(1,392
|
)
|
|
(1,188
|
)
|
|
(1,747
|
)
|
|
(1,242
|
)
|
|||||
|
Financing activities
|
(34,774
|
)
|
|
(16,490
|
)
|
|
77,088
|
|
|
(842
|
)
|
|
(2,954
|
)
|
|||||
|
(1)
|
Gross margin is computed by dividing gross profit by revenue.
|
|
(2)
|
The change in capital structure resulting from the consummation of the mergers and reverse recapitalization has been given retroactive effect in the calculation of net loss per share attributable to common stockholders based on the restated weighted average number of shares of our Common Stock outstanding, as discussed in the introductory paragraph to this Item 6. In accounting for the reverse recapitalization, the historical capitalization related to shares of RSI Common Stock have been retroactively restated based on the Exchange Ratio as if shares of Common Stock had been issued as of the later of (i) the issuance date of the shares, or (ii) the earliest period presented herein. With respect to RSI Preferred Stock, conversion to shares of Common Stock required the affirmative vote by the respective holders of RSI Preferred Stock. Therefore, conversion is not reflected until
October 10, 2017
, and the capital structure of RMNI is deemed to include the RSI Preferred Stock until consummation of the mergers. For purposes of the calculation of diluted net loss per share for all periods, all shares of RSI’s Series A, B and C Preferred Stock and all common stock equivalents have been excluded from the weighted average number of common shares outstanding since the impact was anti-dilutive.
|
|
|
|
|
Variance
|
||||||||||
|
|
2018
|
|
2017
|
|
Amount
|
|
Percent
|
||||||
|
Revenue
|
$
|
252,790
|
|
|
$
|
212,633
|
|
|
$
|
40,157
|
|
|
18.9%
|
|
Cost of revenue
|
95,981
|
|
|
82,898
|
|
|
13,083
|
|
|
15.8%
|
|||
|
Gross profit
|
156,809
|
|
|
129,735
|
|
|
27,074
|
|
|
20.9%
|
|||
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||
|
Sales and marketing
|
93,215
|
|
|
66,759
|
|
|
26,456
|
|
|
39.6%
|
|||
|
General and administrative
|
36,982
|
|
|
36,144
|
|
|
838
|
|
|
2.3%
|
|||
|
Litigation costs and related recoveries, net
|
1,258
|
|
|
4,860
|
|
|
(3,602
|
)
|
|
(74.1)%
|
|||
|
Total operating expenses
|
131,455
|
|
|
107,763
|
|
|
23,692
|
|
|
22.0%
|
|||
|
Operating income
|
25,354
|
|
|
21,972
|
|
|
3,382
|
|
|
15.4%
|
|||
|
Non-operating expenses:
|
|
|
|
|
|
|
|
||||||
|
Interest expense
|
(32,530
|
)
|
|
(43,357
|
)
|
|
10,827
|
|
|
(25.0)%
|
|||
|
Other debt financing expenses
|
(58,331
|
)
|
|
(18,361
|
)
|
|
(39,970
|
)
|
|
217.7%
|
|||
|
Gain (loss) from change in fair value of redeemable warrants
|
—
|
|
|
(16,352
|
)
|
|
16,352
|
|
|
(100.0)%
|
|||
|
Gain (loss) from change in fair value of embedded derivatives
|
1,600
|
|
|
3,800
|
|
|
(2,200
|
)
|
|
(57.9)%
|
|||
|
Other income (expense), net
|
(2,066
|
)
|
|
320
|
|
|
(2,386
|
)
|
|
(745.6)%
|
|||
|
Loss before income taxes
|
(65,973
|
)
|
|
(51,978
|
)
|
|
(13,995
|
)
|
|
26.9%
|
|||
|
Income tax expense
|
(1,992
|
)
|
|
(1,319
|
)
|
|
(673
|
)
|
|
51.0%
|
|||
|
Net loss
|
$
|
(67,965
|
)
|
|
$
|
(53,297
|
)
|
|
$
|
(14,668
|
)
|
|
27.5%
|
|
|
|
|
|
|
Variance
|
||||||||
|
|
2018
|
|
2017
|
|
Amount
|
|
Percent
|
||||||
|
Revenue
|
$
|
252,790
|
|
|
$
|
212,633
|
|
|
$
|
40,157
|
|
|
18.9%
|
|
Cost of revenue:
|
|
|
|
|
|
|
|
|
|||||
|
Employee compensation and benefits
|
64,158
|
|
|
54,591
|
|
|
9,567
|
|
|
17.5%
|
|||
|
Engineering consulting costs
|
13,946
|
|
|
14,683
|
|
|
(737
|
)
|
|
(5.0)%
|
|||
|
Administrative allocations
(1)
|
10,715
|
|
|
9,041
|
|
|
1,674
|
|
|
18.5%
|
|||
|
All other costs
|
7,162
|
|
|
4,583
|
|
|
2,579
|
|
|
56.3%
|
|||
|
Total cost of revenue
|
95,981
|
|
|
82,898
|
|
|
13,083
|
|
|
15.8%
|
|||
|
Gross profit
|
$
|
156,809
|
|
|
$
|
129,735
|
|
|
$
|
27,074
|
|
|
20.9%
|
|
Gross margin
|
62.0%
|
|
61.0%
|
|
|
|
|
|
|||||
|
(1)
|
Includes the portion of costs for information technology, security services and facilities costs that are allocated to cost of revenue. In our consolidated financial statements, such costs are allocated between cost of revenue, sales and marketing, and general and administrative expenses based primarily on relative headcount, except for facilities which is based on occupancy.
|
|
|
2018
|
|
2017
|
|
Change
|
||||||
|
Professional fees and other defense costs of litigation
|
$
|
30,126
|
|
|
$
|
17,171
|
|
|
$
|
12,955
|
|
|
Litigation appeal refund
|
(21,285
|
)
|
|
—
|
|
|
(21,285
|
)
|
|||
|
Insurance recoveries, net
|
(7,583
|
)
|
|
(12,311
|
)
|
|
4,728
|
|
|||
|
Litigation costs, net of related insurance recoveries
|
$
|
1,258
|
|
|
$
|
4,860
|
|
|
$
|
(3,602
|
)
|
|
|
|
|
Variance
|
||||||||||
|
|
2017
|
|
2016
|
|
Amount
|
|
Percent
|
||||||
|
Revenue
|
$
|
212,633
|
|
|
$
|
160,175
|
|
|
$
|
52,458
|
|
|
32.8%
|
|
Cost of revenue
|
82,898
|
|
|
67,045
|
|
|
15,853
|
|
|
23.6%
|
|||
|
Gross profit
|
129,735
|
|
|
93,130
|
|
|
36,605
|
|
|
39.3%
|
|||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
||||
|
Sales and marketing
|
66,759
|
|
|
72,936
|
|
|
(6,177
|
)
|
|
(8.5)%
|
|||
|
General and administrative
|
36,144
|
|
|
36,212
|
|
|
(68
|
)
|
|
(0.2)%
|
|||
|
Litigation costs and related recoveries, net
|
4,860
|
|
|
(29,949
|
)
|
|
34,809
|
|
|
(116.2)%
|
|||
|
Total operating expenses
|
107,763
|
|
|
79,199
|
|
|
28,564
|
|
|
36.1%
|
|||
|
Operating income (loss)
|
21,972
|
|
|
13,931
|
|
|
8,041
|
|
|
57.7%
|
|||
|
Non-operating expenses:
|
|
|
|
|
|
|
|
|
|
||||
|
Interest expense
|
(43,357
|
)
|
|
(13,356
|
)
|
|
(30,001
|
)
|
|
224.6%
|
|||
|
Other debt financing expenses
|
(18,361
|
)
|
|
(6,372
|
)
|
|
(11,989
|
)
|
|
188.2%
|
|||
|
Gain (loss) on change in fair value of redeemable warrants
|
(16,352
|
)
|
|
1,578
|
|
|
(17,930
|
)
|
|
(1,136.2)%
|
|||
|
Gain (loss) on change in fair value of embedded derivatives
|
3,800
|
|
|
(5,400
|
)
|
|
9,200
|
|
|
(170.4)%
|
|||
|
Other, net
|
320
|
|
|
(1,786
|
)
|
|
2,106
|
|
|
(117.9)%
|
|||
|
Loss before income taxes
|
(51,978
|
)
|
|
(11,405
|
)
|
|
(40,573
|
)
|
|
355.7%
|
|||
|
Income tax expense
|
(1,319
|
)
|
|
(1,532
|
)
|
|
213
|
|
|
(13.9)%
|
|||
|
Net loss
|
$
|
(53,297
|
)
|
|
$
|
(12,937
|
)
|
|
$
|
(40,360
|
)
|
|
312.0%
|
|
|
|
|
|
|
Variance
|
||||||||
|
|
2017
|
|
2016
|
|
Amount
|
|
Percent
|
||||||
|
Revenue
|
$
|
212,633
|
|
|
$
|
160,175
|
|
|
$
|
52,458
|
|
|
32.8%
|
|
Cost of revenue:
|
|
|
|
|
|
|
|
|
|
|
|||
|
Employee compensation and benefits
|
54,591
|
|
|
44,659
|
|
|
9,932
|
|
|
22.2%
|
|||
|
Engineering consulting costs
|
14,683
|
|
|
10,180
|
|
|
4,503
|
|
|
44.2%
|
|||
|
Administrative allocations
(1)
|
9,041
|
|
|
8,101
|
|
|
940
|
|
|
11.6%
|
|||
|
All other costs
|
4,583
|
|
|
4,105
|
|
|
478
|
|
|
11.6%
|
|||
|
Total cost of revenue
|
82,898
|
|
|
67,045
|
|
|
15,853
|
|
|
23.6%
|
|||
|
Gross profit
|
$
|
129,735
|
|
|
$
|
93,130
|
|
|
$
|
36,605
|
|
|
39.3%
|
|
Gross margin
|
61.0%
|
|
58.1%
|
|
|
|
|
|
|||||
|
(1)
|
Includes the portion of costs for information technology, security services and facilities costs that are allocated to cost of revenue. In our consolidated financial statements, the total of such costs is allocated between cost of revenue, sales and marketing, and general and administrative expenses, based primarily on relative headcount, except for facilities which is based on occupancy.
|
|
|
2017
|
|
2016
|
|
Variance
|
||||||
|
Professional fees and other defense costs of litigation
|
$
|
17,171
|
|
|
$
|
21,379
|
|
|
$
|
(4,208
|
)
|
|
Insurance recoveries and reduction in deferred settlement liability
|
(12,311
|
)
|
|
(54,248
|
)
|
|
41,937
|
|
|||
|
Pre-judgment interest on litigation judgment
|
—
|
|
|
2,920
|
|
|
(2,920
|
)
|
|||
|
Litigation costs, net of related insurance recoveries
|
$
|
4,860
|
|
|
$
|
(29,949
|
)
|
|
$
|
34,809
|
|
|
|
|
Cash
|
|
PIK
|
|
Total
|
||||||
|
Year Ending December 31:
|
|
|
|
|
|
|
||||||
|
2019
|
|
$
|
14,351
|
|
|
$
|
4,305
|
|
|
$
|
18,656
|
|
|
2020
|
|
14,787
|
|
|
4,436
|
|
|
19,223
|
|
|||
|
2021
|
|
15,235
|
|
|
4,571
|
|
|
19,806
|
|
|||
|
2022
|
|
15,698
|
|
|
4,709
|
|
|
20,407
|
|
|||
|
2023
|
|
8,838
|
|
|
2,652
|
|
|
11,490
|
|
|||
|
Total
|
|
$
|
68,909
|
|
|
$
|
20,673
|
|
|
$
|
89,582
|
|
|
|
2018
|
|
2017
|
||||
|
Note payable to GP Sponsor, net of discount
|
$
|
2,372
|
|
|
$
|
2,059
|
|
|
Credit Facility, net of discount
|
—
|
|
|
80,054
|
|
||
|
Total
|
2,372
|
|
|
82,113
|
|
||
|
Less current maturities
|
2,372
|
|
|
15,500
|
|
||
|
Long-term debt, net of current maturities
|
$
|
—
|
|
|
$
|
66,613
|
|
|
Contractual principal and exit fees:
|
|
||
|
Principal balance
|
$
|
102,576
|
|
|
Mandatory trigger event exit fees
|
13,624
|
|
|
|
Mandatory consulting
|
2,000
|
|
|
|
Subtotal
|
118,200
|
|
|
|
Make-whole applicable premium
|
7,307
|
|
|
|
Amendment fees and related liabilities
|
6,250
|
|
|
|
Accrued interest and fees payable
|
1,073
|
|
|
|
Total cash termination payments
|
$
|
132,830
|
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net cash provided by (used in):
|
|
|
|
|
|
|
|
|
|||
|
Operating activities
|
$
|
22,382
|
|
|
$
|
29,163
|
|
|
$
|
(59,609
|
)
|
|
Investing activities
|
(1,053
|
)
|
|
(1,392
|
)
|
|
(1,188
|
)
|
|||
|
Financing activities
|
(34,774
|
)
|
|
(16,490
|
)
|
|
77,088
|
|
|||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net loss
|
$
|
(67,965
|
)
|
|
$
|
(53,297
|
)
|
|
$
|
(12,937
|
)
|
|
Non-cash expenses, net
|
74,854
|
|
|
57,672
|
|
|
18,403
|
|
|||
|
Non-operating expense
|
10,410
|
|
|
4,607
|
|
|
—
|
|
|||
|
Changes in operating assets and liabilities, net
|
5,083
|
|
|
20,181
|
|
|
(65,075
|
)
|
|||
|
Net cash provided by (used in) operating activities
|
$
|
22,382
|
|
|
$
|
29,163
|
|
|
$
|
(59,609
|
)
|
|
|
Year Ending December 31:
|
|
|
||||||||||||||||||||||||
|
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
2023
|
|
Thereafter
|
|
Total
|
||||||||||||||
|
Series A Preferred Stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Cash Dividends at 10.0% per annum
|
$
|
14,351
|
|
|
$
|
14,787
|
|
|
$
|
15,235
|
|
|
$
|
15,698
|
|
|
$
|
8,838
|
|
|
$
|
—
|
|
|
$
|
68,909
|
|
|
PIK Dividends at 3.0% per annum
(1)
|
4,305
|
|
|
4,436
|
|
|
4,571
|
|
|
4,709
|
|
|
2,652
|
|
|
—
|
|
|
20,673
|
|
|||||||
|
Assumed redemption
(2)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
140,846
|
|
|
—
|
|
|
140,846
|
|
|||||||
|
GP Sponsor Note Payable:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Principal
(3)
|
2,555
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,555
|
|
|||||||
|
Interest
(3)
|
96
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
96
|
|
|||||||
|
Lease obligations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Operating
|
4,942
|
|
|
4,058
|
|
|
3,765
|
|
|
2,936
|
|
|
370
|
|
|
349
|
|
|
16,420
|
|
|||||||
|
Capital
|
414
|
|
|
155
|
|
|
72
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
641
|
|
|||||||
|
Total
|
$
|
26,663
|
|
|
$
|
23,436
|
|
|
$
|
23,643
|
|
|
$
|
23,343
|
|
|
$
|
152,706
|
|
|
$
|
349
|
|
|
$
|
250,140
|
|
|
(1)
|
PIK Dividends are accrued quarterly in arrears at
3.0%
per annum for the first five years following the
July 19, 2018
original issuance date. The accrued PIK Dividends are settled quarterly through the issuance of additional shares of Series A Preferred Stock. Accordingly, the PIK shares of Series A Preferred Stock may be converted to Common Stock or subject to the holders' redemption rights beginning on
July 19, 2023
(and earlier under certain circumstances).
|
|
(2)
|
As discussed in Note
6
to our consolidated financial statements included in Item 8 of this Report, the Series A Preferred Stock will become mandatorily redeemable, upon the election by the holders of a majority of the then outstanding Preferred Stock, on or after
July 19, 2023
. For purposes of this table, we have assumed that holders of Series A Preferred Stock do not elect to exercise their right to convert to Common Stock and we do not elect to redeem any shares prior to
July 19, 2023
. Rather, we have assumed that the holders elect to require us to redeem all outstanding shares of Series A Preferred Stock on
July 19, 2023
for the entire liquidation preference of
$140.8 million
that is outstanding as of
December 31, 2018
. Under this scenario, the cumulative PIK Dividends of
$20.7 million
shown in the table above would also be subject to redemption on
July 19, 2023
.
|
|
(3)
|
As discussed in Note
5
to our consolidated financial statements included in Item 8 of this Report, on
December 21, 2018
, the GP Sponsor Note Payable was amended to provide an extension of the maturity date from
January 4, 2019
to
June 28, 2019
. In addition, we agreed that the loan would retroactively bear interest at
13.0%
per annum from
July 19, 2018
through the amended maturity date. The second amendment provides for monthly principal payments of approximately
$0.4 million
plus accrued interest through the maturity date.
|
|
•
|
Persuasive evidence of an arrangement exists
. We generally rely on a written sales contract to determine the existence of an arrangement.
|
|
•
|
Delivery has occurred
. We consider delivery to have occurred over the contractual term when support service is available to the customer in the manner prescribed in the contractual arrangement, and when there are no further additional performance or delivery obligations.
|
|
•
|
Fee is fixed or determinable
. We assess whether the sales price is fixed or determinable based on the payment terms and whether the sales price is subject to refund or adjustment.
|
|
•
|
Collection is reasonably assured
. Collection is deemed probable if we expect that the customer will be able to pay amounts under the arrangement as payments become due. Previous uncollectable receivables have not had a material impact on the consolidated financial statements for the periods presented.
|
|
|
|
Page
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
/s/ KPMG LLP
|
|
|
|
2018
|
|
2017
|
||||
|
ASSETS
|
|
|
|
|
|
||
|
Current assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
24,771
|
|
|
$
|
21,950
|
|
|
Restricted cash
|
435
|
|
|
18,077
|
|
||
|
Accounts receivable, net of allowance of $489 and $51, respectively
|
80,599
|
|
|
63,525
|
|
||
|
Prepaid expenses and other
|
7,099
|
|
|
8,560
|
|
||
|
Total current assets
|
112,904
|
|
|
112,112
|
|
||
|
Long-term assets:
|
|
|
|
||||
|
Property and equipment, net
|
3,634
|
|
|
4,255
|
|
||
|
Deferred debt issuance costs, net
|
—
|
|
|
3,520
|
|
||
|
Deposits and other
|
1,438
|
|
|
1,565
|
|
||
|
Deferred income taxes, net
|
909
|
|
|
719
|
|
||
|
Total assets
|
$
|
118,885
|
|
|
$
|
122,171
|
|
|
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
|
||
|
Current maturities of long-term debt
|
$
|
2,372
|
|
|
$
|
15,500
|
|
|
Accounts payable
|
12,851
|
|
|
10,137
|
|
||
|
Accrued compensation, benefits and commissions
|
22,503
|
|
|
18,154
|
|
||
|
Other accrued liabilities
|
20,424
|
|
|
32,553
|
|
||
|
Deferred revenue
|
180,358
|
|
|
152,390
|
|
||
|
Total current liabilities
|
238,508
|
|
|
228,734
|
|
||
|
Long-term liabilities:
|
|
|
|
||||
|
Long-term debt, net of current maturities
|
—
|
|
|
66,613
|
|
||
|
Deferred revenue
|
28,898
|
|
|
29,182
|
|
||
|
Accrued PIK dividends payable
|
1,056
|
|
|
—
|
|
||
|
Other long-term liabilities
|
2,011
|
|
|
7,943
|
|
||
|
Total liabilities
|
270,473
|
|
|
332,472
|
|
||
|
Commitments and contingencies (Note 10)
|
|
|
|
|
|
||
|
Redeemable Series A Preferred Stock.
Authorized 180 shares, issued and outstanding 141 shares. Liquidation preference of $140,846; net of discount of $26,848
|
113,998
|
|
|
—
|
|
||
|
Stockholders’ deficit:
|
|
|
|
|
|
||
|
Preferred stock, $0.0001 par value per share. Authorized 99,820 shares (excluding 180 shares of Series A Preferred Stock); no other series has been designated
|
—
|
|
|
—
|
|
||
|
Common stock, $0.0001 par value. Authorized 1,000,000 shares; issued and outstanding 64,193 and 59,314 shares as of December 31, 2018 and 2017, respectively
|
6
|
|
|
6
|
|
||
|
Additional paid-in capital
|
108,347
|
|
|
94,967
|
|
||
|
Accumulated other comprehensive loss
|
(1,567
|
)
|
|
(867
|
)
|
||
|
Accumulated deficit
|
(372,372
|
)
|
|
(304,407
|
)
|
||
|
Total stockholders' deficit
|
(265,586
|
)
|
|
(210,301
|
)
|
||
|
Total liabilities, redeemable preferred stock and stockholders' deficit
|
$
|
118,885
|
|
|
$
|
122,171
|
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Revenue
|
$
|
252,790
|
|
|
$
|
212,633
|
|
|
$
|
160,175
|
|
|
Cost of revenue
|
95,981
|
|
|
82,898
|
|
|
67,045
|
|
|||
|
Gross profit
|
156,809
|
|
|
129,735
|
|
|
93,130
|
|
|||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|||
|
Sales and marketing
|
93,215
|
|
|
66,759
|
|
|
72,936
|
|
|||
|
General and administrative
|
36,982
|
|
|
36,144
|
|
|
36,212
|
|
|||
|
Litigation costs and related recoveries, net
|
1,258
|
|
|
4,860
|
|
|
(29,949
|
)
|
|||
|
Total operating expenses
|
131,455
|
|
|
107,763
|
|
|
79,199
|
|
|||
|
Operating income
|
25,354
|
|
|
21,972
|
|
|
13,931
|
|
|||
|
Non-operating expenses:
|
|
|
|
|
|
||||||
|
Interest expense
|
(32,530
|
)
|
|
(43,357
|
)
|
|
(13,356
|
)
|
|||
|
Other debt financing expenses
|
(58,331
|
)
|
|
(18,361
|
)
|
|
(6,372
|
)
|
|||
|
Gain (loss) from change in fair value of redeemable warrants
|
—
|
|
|
(16,352
|
)
|
|
1,578
|
|
|||
|
Gain (loss) from change in fair value of embedded derivatives
|
1,600
|
|
|
3,800
|
|
|
(5,400
|
)
|
|||
|
Other income (expense), net
|
(2,066
|
)
|
|
320
|
|
|
(1,786
|
)
|
|||
|
Loss before income taxes
|
(65,973
|
)
|
|
(51,978
|
)
|
|
(11,405
|
)
|
|||
|
Income tax expense
|
(1,992
|
)
|
|
(1,319
|
)
|
|
(1,532
|
)
|
|||
|
Net loss
|
(67,965
|
)
|
|
(53,297
|
)
|
|
(12,937
|
)
|
|||
|
Other comprehensive income (loss):
|
|
|
|
|
|
||||||
|
Foreign currency gain (loss)
|
(700
|
)
|
|
179
|
|
|
(500
|
)
|
|||
|
Comprehensive loss
|
$
|
(68,665
|
)
|
|
$
|
(53,118
|
)
|
|
$
|
(13,437
|
)
|
|
|
|
|
|
|
|
||||||
|
Net loss attributable to common stockholders
|
$
|
(78,606
|
)
|
|
$
|
(53,297
|
)
|
|
$
|
(22,937
|
)
|
|
Net loss per share attributable to common stockholders (basic and diluted)
(1)
|
$
|
(1.28
|
)
|
|
$
|
(1.65
|
)
|
|
$
|
(0.95
|
)
|
|
Weighted average number of shares of Common Stock outstanding (basic and diluted)
(1)
|
61,384
|
|
|
32,229
|
|
|
24,262
|
|
|||
|
(1)
|
See Note 1 for discussion of reverse recapitalization given effect herein.
|
|
|
RSI Convertible
Preferred Stock
(1)
|
|
Common Stock
(1)
|
|
Additional Paid-in Capital
(1)
|
|
Accumulated Other Comprehensive Loss
|
|
Accumulated Deficit
|
|
|
||||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|
|
|
Total
|
|||||||||||||||||
|
Balances, December 31, 2015
|
44,045
|
|
|
$
|
9,635
|
|
|
24,247
|
|
|
$
|
2
|
|
|
$
|
16,763
|
|
|
$
|
(546
|
)
|
|
$
|
(238,173
|
)
|
|
$
|
(212,319
|
)
|
|
Issuance of Series C Preferred Stock
|
56,441
|
|
|
10,001
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,001
|
|
||||||
|
RSI Series C Convertible Preferred Stock offering costs
|
—
|
|
|
(94
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(94
|
)
|
||||||
|
Beneficial conversion feature of Series C Preferred Stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,000
|
|
|
—
|
|
|
—
|
|
|
10,000
|
|
||||||
|
Deemed dividend for beneficial conversion features
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(10,000
|
)
|
|
—
|
|
|
—
|
|
|
(10,000
|
)
|
||||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,297
|
|
|
—
|
|
|
—
|
|
|
2,297
|
|
||||||
|
Warrant fair value adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7
|
)
|
|
—
|
|
|
—
|
|
|
(7
|
)
|
||||||
|
Issuance of shares upon exercise of stock options
|
—
|
|
|
—
|
|
|
35
|
|
|
—
|
|
|
49
|
|
|
—
|
|
|
—
|
|
|
49
|
|
||||||
|
Foreign currency translation loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(500
|
)
|
|
—
|
|
|
(500
|
)
|
||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(12,937
|
)
|
|
(12,937
|
)
|
||||||
|
Balances, December 31, 2016
|
100,486
|
|
|
19,542
|
|
|
24,282
|
|
|
2
|
|
|
19,102
|
|
|
(1,046
|
)
|
|
(251,110
|
)
|
|
(213,510
|
)
|
||||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,963
|
|
|
—
|
|
|
—
|
|
|
2,963
|
|
||||||
|
Warrant fair value adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
380
|
|
|
—
|
|
|
—
|
|
|
380
|
|
||||||
|
Exercise of stock options for cash
|
—
|
|
|
—
|
|
|
1,219
|
|
|
—
|
|
|
872
|
|
|
—
|
|
|
—
|
|
|
872
|
|
||||||
|
Give effect to Mergers and reverse recapitalization:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Conversion of RSI Preferred Stock
|
(100,486
|
)
|
|
(19,542
|
)
|
|
24,058
|
|
|
3
|
|
|
19,539
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Cashless exercise of warrant
|
—
|
|
|
—
|
|
|
43
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Elimination of redemption liability for Origination Agent warrants
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
23,621
|
|
|
—
|
|
|
—
|
|
|
23,621
|
|
||||||
|
Issuance of Common Stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Net equity infusion from Mergers
|
—
|
|
|
—
|
|
|
9,324
|
|
|
1
|
|
|
38,926
|
|
|
—
|
|
|
—
|
|
|
38,927
|
|
||||||
|
Financial advisors for transaction costs
|
—
|
|
|
—
|
|
|
388
|
|
|
—
|
|
|
3,884
|
|
|
—
|
|
|
—
|
|
|
3,884
|
|
||||||
|
Transaction costs incurred by RSI
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,282
|
)
|
|
—
|
|
|
—
|
|
|
(14,282
|
)
|
||||||
|
Cash paid to settle stock options of former employees
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(38
|
)
|
|
—
|
|
|
—
|
|
|
(38
|
)
|
||||||
|
Foreign currency translation gain
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
179
|
|
|
—
|
|
|
179
|
|
||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(53,297
|
)
|
|
(53,297
|
)
|
||||||
|
Balances, December 31, 2017
|
—
|
|
|
—
|
|
|
59,314
|
|
|
6
|
|
|
94,967
|
|
|
(867
|
)
|
|
(304,407
|
)
|
|
(210,301
|
)
|
||||||
|
Stock-based compensation expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,394
|
|
|
—
|
|
|
—
|
|
|
4,394
|
|
||||||
|
Exercise of stock options for cash
|
—
|
|
|
—
|
|
|
1,982
|
|
|
—
|
|
|
2,034
|
|
|
—
|
|
|
—
|
|
|
2,034
|
|
||||||
|
Issuance of Common Stock in Private Placement, net
|
—
|
|
|
—
|
|
|
2,897
|
|
|
—
|
|
|
17,593
|
|
|
—
|
|
|
—
|
|
|
17,593
|
|
||||||
|
Accretion of discount on Series A Preferred Stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,373
|
)
|
|
—
|
|
|
—
|
|
|
(2,373
|
)
|
||||||
|
Accrued dividends on Series A Preferred Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Paid and payable in cash
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(6,366
|
)
|
|
—
|
|
|
—
|
|
|
(6,366
|
)
|
||||||
|
Paid and payable in kind
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,902
|
)
|
|
—
|
|
|
—
|
|
|
(1,902
|
)
|
||||||
|
Foreign currency translation loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(700
|
)
|
|
—
|
|
|
(700
|
)
|
||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(67,965
|
)
|
|
(67,965
|
)
|
||||||
|
Balances, December 31, 2018
|
—
|
|
|
$
|
—
|
|
|
64,193
|
|
|
$
|
6
|
|
|
$
|
108,347
|
|
|
$
|
(1,567
|
)
|
|
$
|
(372,372
|
)
|
|
$
|
(265,586
|
)
|
|
(1)
|
See Note 1 for discussion of reverse recapitalization given effect herein.
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|||
|
Net loss
|
$
|
(67,965
|
)
|
|
$
|
(53,297
|
)
|
|
$
|
(12,937
|
)
|
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
|
|
|
|
|
||||||
|
Accretion and amortization of debt discount and issuance costs
|
13,331
|
|
|
24,890
|
|
|
10,121
|
|
|||
|
Write-off of debt discount and issuance costs
|
54,536
|
|
|
12,071
|
|
|
—
|
|
|||
|
Loss (gain) from change in fair value of redeemable warrants
|
—
|
|
|
16,352
|
|
|
(1,578
|
)
|
|||
|
Loss (gain) from change in fair value of embedded derivatives
|
(1,600
|
)
|
|
(3,800
|
)
|
|
5,400
|
|
|||
|
Paid-in-kind interest expense
|
1,886
|
|
|
2,966
|
|
|
900
|
|
|||
|
Stock-based compensation expense
|
4,394
|
|
|
2,963
|
|
|
2,297
|
|
|||
|
Depreciation and amortization
|
1,838
|
|
|
1,973
|
|
|
1,783
|
|
|||
|
Write-off of deferred debt financing costs
|
704
|
|
|
—
|
|
|
—
|
|
|||
|
Deferred income taxes
|
(235
|
)
|
|
(124
|
)
|
|
(520
|
)
|
|||
|
Other
|
—
|
|
|
381
|
|
|
—
|
|
|||
|
Make-whole applicable premium included in interest expense
|
10,410
|
|
|
4,607
|
|
|
—
|
|
|||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
||||||
|
Accounts receivable
|
(18,036
|
)
|
|
(8,348
|
)
|
|
(14,663
|
)
|
|||
|
Prepaid expenses, deposits and other
|
860
|
|
|
(3,279
|
)
|
|
(1,427
|
)
|
|||
|
Accounts payable
|
2,875
|
|
|
1,200
|
|
|
4,636
|
|
|||
|
Accrued compensation, benefits, commissions and other liabilities
|
(1,541
|
)
|
|
5,623
|
|
|
10,759
|
|
|||
|
Deferred insurance settlement
|
(8,033
|
)
|
|
8,033
|
|
|
—
|
|
|||
|
Accrued litigation settlement
|
—
|
|
|
—
|
|
|
(121,411
|
)
|
|||
|
Deferred revenue
|
28,958
|
|
|
16,952
|
|
|
57,031
|
|
|||
|
Net cash provided by (used in) operating activities
|
22,382
|
|
|
29,163
|
|
|
(59,609
|
)
|
|||
|
CASH FLOWS USED IN INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|||
|
Capital expenditures
|
(1,053
|
)
|
|
(1,392
|
)
|
|
(1,188
|
)
|
|||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|||
|
Net proceeds from issuance of Series A Preferred Stock and Common Stock in Private Placement
|
133,000
|
|
|
—
|
|
|
—
|
|
|||
|
Principal payments on borrowings
|
(145,807
|
)
|
|
(41,994
|
)
|
|
(15,313
|
)
|
|||
|
Make-whole applicable premium related to prepayment of borrowings
|
(10,410
|
)
|
|
(4,607
|
)
|
|
—
|
|
|||
|
Payments for offering costs
|
(4,288
|
)
|
|
(12,247
|
)
|
|
—
|
|
|||
|
Debt issuance costs paid
|
(5,871
|
)
|
|
(114
|
)
|
|
(560
|
)
|
|||
|
Proceeds from exercise of employee stock options
|
2,034
|
|
|
872
|
|
|
44
|
|
|||
|
Payment of cash dividends on Series A Preferred Stock
|
(2,845
|
)
|
|
—
|
|
|
—
|
|
|||
|
Principal payments on capital leases
|
(587
|
)
|
|
(776
|
)
|
|
(733
|
)
|
|||
|
Proceeds from capital infusion in reverse recapitalization
|
—
|
|
|
42,414
|
|
|
—
|
|
|||
|
Cash paid to settle stock options of former employees
|
—
|
|
|
(38
|
)
|
|
—
|
|
|||
|
Net proceeds from borrowings
|
—
|
|
|
—
|
|
|
83,743
|
|
|||
|
Net proceeds from issuance of Series C Preferred Stock
|
—
|
|
|
—
|
|
|
9,907
|
|
|||
|
Net cash provided by (used in) financing activities
|
(34,774
|
)
|
|
(16,490
|
)
|
|
77,088
|
|
|||
|
Effect of foreign currency changes on cash
|
(1,376
|
)
|
|
509
|
|
|
(613
|
)
|
|||
|
Net change in cash, cash equivalents and restricted cash
|
(14,821
|
)
|
|
11,790
|
|
|
15,678
|
|
|||
|
Cash, cash equivalents and restricted cash at beginning of year
|
40,027
|
|
|
28,237
|
|
|
12,559
|
|
|||
|
Cash, cash equivalents and restricted cash at end of year
|
$
|
25,206
|
|
|
$
|
40,027
|
|
|
$
|
28,237
|
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
|
|
|
|
|
|
|
|
|||
|
Cash paid for interest
|
$
|
19,321
|
|
|
$
|
16,542
|
|
|
$
|
2,972
|
|
|
Cash paid for income taxes
|
1,765
|
|
|
1,730
|
|
|
1,609
|
|
|||
|
|
|
|
|
|
|
||||||
|
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
|
|
|
|
|
||||||
|
Discount on shares issued in Private Placement:
|
|
|
|
|
|
||||||
|
Fair value of 2,897 shares of Common Stock issued for no consideration
|
20,131
|
|
|
—
|
|
|
—
|
|
|||
|
Original issuance discount on Series A Preferred Stock
|
7,000
|
|
|
—
|
|
|
—
|
|
|||
|
Redeemable Series A Preferred Stock Dividends and Accretion:
|
|
|
|
|
|
||||||
|
Accrued cash dividends
|
3,521
|
|
|
—
|
|
|
—
|
|
|||
|
Accrued PIK dividends
|
1,056
|
|
|
—
|
|
|
—
|
|
|||
|
Accretion of discount on Series A Preferred Stock
|
2,373
|
|
|
—
|
|
|
—
|
|
|||
|
Issuance of Series A Preferred Stock for PIK Dividends
|
846
|
|
|
—
|
|
|
—
|
|
|||
|
Liability for mandatory fees and related debt discount under Credit Facility:
|
|
|
|
|
|
||||||
|
Adjustment for updated calculation of mandatory trigger event exit fees
|
3,952
|
|
|
9,414
|
|
|
9,957
|
|
|||
|
Balance at inception of Credit Facility
|
—
|
|
|
—
|
|
|
45,301
|
|
|||
|
Adjustment for mandatory consulting fees due to amendment
|
—
|
|
|
—
|
|
|
6,000
|
|
|||
|
Increase in principal for debt discount on GP Sponsor loan
|
167
|
|
|
—
|
|
|
—
|
|
|||
|
Purchase of equipment under capital lease obligations
|
353
|
|
|
214
|
|
|
868
|
|
|||
|
Increase in payables for:
|
|
|
|
|
|
||||||
|
Capital expenditures
|
—
|
|
|
65
|
|
|
47
|
|
|||
|
Debt discount for amendment fees under Credit Facility
|
—
|
|
|
5,000
|
|
|
—
|
|
|||
|
Credit Facility exit fee obligations converted to principal
|
—
|
|
|
50,000
|
|
|
—
|
|
|||
|
Elimination of redemption liability for Origination Agent warrants
|
—
|
|
|
23,621
|
|
|
—
|
|
|||
|
Conversion of RSI Preferred Stock to Common Stock in connection with the Mergers
|
—
|
|
|
19,542
|
|
|
—
|
|
|||
|
Issuance of Common Stock in connection with the Mergers:
|
|
|
|
|
|
|
|
|
|||
|
RSI financial advisor for transaction costs
|
—
|
|
|
2,375
|
|
|
—
|
|
|||
|
GPIA deferred underwriting fee liability as reduction of capital infusion
|
—
|
|
|
1,509
|
|
|
—
|
|
|||
|
Assumption of note payable to GP Sponsor in connection with the Mergers
|
—
|
|
|
1,992
|
|
|
—
|
|
|||
|
Acquisition of prepaid expenses in connection with the Mergers
|
—
|
|
|
14
|
|
|
—
|
|
|||
|
Deemed dividend for beneficial conversion feature related to RSI Preferred Stock
|
—
|
|
|
—
|
|
|
10,000
|
|
|||
|
Issuance of redeemable warrant in connection with the Credit Facility
|
—
|
|
|
—
|
|
|
8,847
|
|
|||
|
|
|
Years
|
|
Computer equipment
|
|
1-3
|
|
Furniture and fixtures
|
|
3-7
|
|
Capitalized software costs
|
|
3
|
|
Leasehold improvements
|
|
Up to 8 years, not to exceed lease term
|
|
•
|
Persuasive evidence of an arrangement exists
. The Company generally relies on a written sales contract to determine the existence of an arrangement.
|
|
•
|
Delivery has occurred
. The Company considers delivery to have occurred over the contractual term when support service is available to the customer in the manner prescribed in the contractual arrangement, and when there are no further additional performance or delivery obligations.
|
|
•
|
Fee is fixed or determinable
. The Company assesses whether the sales price is fixed or determinable based on the payment terms and whether the sales price is subject to refund or adjustment.
|
|
•
|
Collection is reasonably assured
. Collection is deemed probable if the Company expects that the customer will be able to pay amounts under the arrangement as payments become due. Previous uncollectable receivables have not had a material impact on the consolidated financial statements for the periods presented.
|
|
|
Total
Shares
|
|
Available
Cash
|
|||
|
Balances, October 9, 2017
|
20,009,776
|
|
|
$
|
158,219
|
|
|
Less redemption of GPIA shares prior to the Mergers
|
(14,286,064
|
)
|
|
(143,904
|
)
|
|
|
Balances before backstop equity financing
|
5,723,712
|
|
|
14,315
|
|
|
|
GP Sponsor subscription for 3,600,000 shares at $10.00 per share
|
3,600,000
|
|
|
36,000
|
|
|
|
Balances prior to consummation of the Mergers
|
9,323,712
|
|
|
$
|
50,315
|
|
|
GPIA available cash prior to consummation of the Mergers
|
$
|
50,315
|
|
|
Less permitted cash payments prior to consummation of the Mergers:
|
|
||
|
GPIA deferred underwriting fee liability
|
(4,550
|
)
|
|
|
GPIA transaction costs related to the Mergers
|
(3,351
|
)
|
|
|
Net cash proceeds upon consummation of the Mergers
|
42,414
|
|
|
|
Other GPIA assets acquired and liabilities assumed in Mergers:
|
|
||
|
Prepaid expenses
|
14
|
|
|
|
Deferred underwriting fee liability settled in shares of Common Stock
|
(1,509
|
)
|
|
|
Assumed note payable to GP Sponsor
|
(1,992
|
)
|
|
|
Net equity infusion from GPIA as of October 10, 2017
|
$
|
38,927
|
|
|
RSI Capital Stock
|
|
Number of
|
|
|
|||
|
Type
|
|
Series/ Class
|
|
Shares
|
|
|
|
|
Preferred
|
|
A
|
|
5,499,900
|
|
|
(1)
|
|
Preferred
|
|
B
|
|
38,545,560
|
|
|
(1)
|
|
Preferred
|
|
C
|
|
56,441,036
|
|
|
(1)
|
|
Common
|
|
A
|
|
529,329
|
|
|
(1)
|
|
Common
|
|
B
|
|
102,925,500
|
|
|
(1)
|
|
Total shares of RSI Capital Stock as of October 10, 2017
|
|
203,941,325
|
|
|
|
||
|
Effect of Exchange Ratio to convert RSI Capital Stock to Common Stock
|
|
48,826,159
|
|
|
(2)
|
||
|
Adjustment for fractional shares
|
|
(67
|
)
|
|
(3)
|
||
|
Cashless exercise of Guarantee Warrant on closing date
|
|
42,556
|
|
|
(4)
|
||
|
Common Stock issued to former RSI stockholders at closing
|
|
48,868,648
|
|
|
|
||
|
(1)
|
Represents the number of shares of RSI Capital Stock issued and outstanding immediately prior to consummation of the Mergers on
October 10, 2017
.
|
|
(2)
|
In accounting for the reverse recapitalization, RSI Capital Stock outstanding as of
October 10, 2017
was converted to shares of RMNI Common Stock based on the Exchange Ratio.
|
|
(3)
|
The total number of shares of RMNI Common Stock issued to the former holders of RSI Capital Stock was net of fractional shares resulting from rounding down in the application of the Exchange Ratio.
|
|
(4)
|
Adams Street Partners and its affiliates (collectively referred to as “ASP”) agreed to exercise on a cashless basis their Guarantee Warrant for
344,828
shares of Rimini Street’s Class A Common Stock at an exercise price of
$1.16
per share immediately prior to consummation of the Mergers. This cashless exercise resulted in the issuance of
177,751
shares of RSI’s Class A Common Stock which converted to
42,556
shares of RMNI Common Stock upon consummation of the Mergers.
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Cash and cash equivalents
|
$
|
24,771
|
|
|
$
|
21,950
|
|
|
$
|
9,385
|
|
|
Restricted cash:
|
|
|
|
|
|
|
|
|
|||
|
Control accounts under Credit Facility
|
—
|
|
|
17,644
|
|
|
18,263
|
|
|||
|
Corporate credit card debts and other
|
435
|
|
|
433
|
|
|
589
|
|
|||
|
Total restricted cash
|
435
|
|
|
18,077
|
|
|
18,852
|
|
|||
|
Total cash, cash equivalents and restricted cash
|
$
|
25,206
|
|
|
$
|
40,027
|
|
|
$
|
28,237
|
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Allowance, beginning of year
|
$
|
51
|
|
|
$
|
36
|
|
|
$
|
115
|
|
|
Provisions
|
491
|
|
|
45
|
|
|
57
|
|
|||
|
Write offs, net of recoveries
|
(53
|
)
|
|
(30
|
)
|
|
(136
|
)
|
|||
|
Allowance, end of year
|
$
|
489
|
|
|
$
|
51
|
|
|
$
|
36
|
|
|
|
2018
|
|
2017
|
||||
|
Prepaid expenses and deposits
|
$
|
3,450
|
|
|
$
|
5,030
|
|
|
Foreign tax refunds receivable
|
1,048
|
|
|
1,292
|
|
||
|
Prepaid loan agent and service fees
|
—
|
|
|
216
|
|
||
|
Other
|
2,601
|
|
|
2,022
|
|
||
|
Total
|
$
|
7,099
|
|
|
$
|
8,560
|
|
|
|
2018
|
|
2017
|
||||
|
Computer equipment
|
$
|
7,853
|
|
|
$
|
6,966
|
|
|
Furniture and fixtures
|
2,632
|
|
|
2,654
|
|
||
|
Capitalized software costs
|
517
|
|
|
433
|
|
||
|
Leasehold improvements
|
1,142
|
|
|
1,090
|
|
||
|
Construction-in-progress
|
33
|
|
|
59
|
|
||
|
Total property and equipment
|
12,177
|
|
|
11,202
|
|
||
|
Less accumulated depreciation
|
(8,543
|
)
|
|
(6,947
|
)
|
||
|
Property and equipment, net
|
$
|
3,634
|
|
|
$
|
4,255
|
|
|
|
2018
|
|
2017
|
||||
|
Accrued sales and other taxes
|
$
|
5,687
|
|
|
$
|
11,266
|
|
|
Accrued professional fees
|
7,035
|
|
|
8,407
|
|
||
|
Accrued dividends on Redeemable Series A Preferred Stock
|
3,521
|
|
|
—
|
|
||
|
Current maturities of capital lease obligations
|
387
|
|
|
533
|
|
||
|
Income taxes payable
|
767
|
|
|
485
|
|
||
|
Appeal proceeds payable to insurance company
|
449
|
|
|
—
|
|
||
|
Deferred insurance settlement
|
—
|
|
|
8,033
|
|
||
|
Liability for embedded derivatives
|
—
|
|
|
1,600
|
|
||
|
Other accrued expenses
|
2,578
|
|
|
2,229
|
|
||
|
Total other accrued liabilities
|
$
|
20,424
|
|
|
$
|
32,553
|
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Professional fees and other defense costs of litigation
|
$
|
30,126
|
|
|
$
|
17,171
|
|
|
$
|
21,379
|
|
|
Litigation appeal refund
|
(21,285
|
)
|
|
—
|
|
|
—
|
|
|||
|
Insurance recoveries and reduction in deferred settlement liability, net
|
(7,583
|
)
|
|
(12,311
|
)
|
|
(54,248
|
)
|
|||
|
Pre-judgment interest on litigation judgment
|
—
|
|
|
—
|
|
|
2,920
|
|
|||
|
Litigation costs and related recoveries, net
|
$
|
1,258
|
|
|
$
|
4,860
|
|
|
$
|
(29,949
|
)
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Interest income:
|
|
|
|
|
|
||||||
|
Post-judgment interest on litigation appeal award
|
$
|
199
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Other
|
54
|
|
|
198
|
|
|
27
|
|
|||
|
Write-off of deferred debt financing costs
|
(704
|
)
|
|
—
|
|
|
—
|
|
|||
|
Foreign currency transaction gain (loss)
|
(1,320
|
)
|
|
191
|
|
|
(1,724
|
)
|
|||
|
Other expenses
|
(295
|
)
|
|
(69
|
)
|
|
(89
|
)
|
|||
|
Total other income (expense), net
|
$
|
(2,066
|
)
|
|
$
|
320
|
|
|
$
|
(1,786
|
)
|
|
|
2018
|
|
2017
|
||||
|
Credit Facility, net of DDIC
|
$
|
—
|
|
|
$
|
80,054
|
|
|
Note payable to GPIA Sponsor, net of DDIC
|
2,372
|
|
|
2,059
|
|
||
|
Total
|
2,372
|
|
|
82,113
|
|
||
|
Less current maturities
|
2,372
|
|
|
15,500
|
|
||
|
Long-term debt, net of current maturities
|
$
|
—
|
|
|
$
|
66,613
|
|
|
Contractual principal and exit fees:
|
|
|
||
|
Principal balance
|
|
$
|
102,576
|
|
|
Mandatory trigger event exit fees
|
|
13,624
|
|
|
|
Mandatory consulting
|
|
2,000
|
|
|
|
Subtotal
|
|
118,200
|
|
|
|
Make-whole applicable premium
|
|
7,307
|
|
|
|
Amendment fees and related liabilities
|
|
6,250
|
|
|
|
Accrued interest and fees payable
|
|
1,073
|
|
|
|
Total cash termination payments
|
|
$
|
132,830
|
|
|
|
|
|
|
|
|
|
Contractual Liability Payments
|
|
|
|
DDIC Write-off
|
|
|
||||||||||||||||||||||||||
|
|
December 31, 2017
|
|
PIK Accrual
|
|
Liability Adjustments
|
|
Scheduled
|
|
Prepayments
|
|
Pay-off
|
|
Accretion Expense
|
|
Prepayments
|
|
Pay-off
|
|
December 31, 2018
|
||||||||||||||||||||
|
Contractual liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Principal balance
|
$
|
125,872
|
|
|
$
|
1,886
|
|
|
$
|
—
|
|
|
$
|
(7,250
|
)
|
|
$
|
(17,932
|
)
|
|
$
|
(102,576
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Mandatory trigger event exit fees
|
9,672
|
|
|
—
|
|
|
3,952
|
|
|
—
|
|
|
—
|
|
|
(13,624
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||||
|
Mandatory consulting fees
|
4,000
|
|
|
—
|
|
|
—
|
|
|
(2,000
|
)
|
|
—
|
|
|
(2,000
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||||
|
Total contractual liabilities
|
139,544
|
|
|
1,886
|
|
|
3,952
|
|
|
(9,250
|
)
|
|
(17,932
|
)
|
|
(118,200
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||||
|
DDIC:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Original issue discount
|
1,816
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(234
|
)
|
|
(1,582
|
)
|
|
—
|
|
||||||||||
|
Origination fee
|
4,538
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(586
|
)
|
|
(3,952
|
)
|
|
—
|
|
||||||||||
|
Amendment fee
|
11,521
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,487
|
)
|
|
(10,034
|
)
|
|
—
|
|
||||||||||
|
Fair value of warrants
|
6,424
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(829
|
)
|
|
(5,595
|
)
|
|
—
|
|
||||||||||
|
Consulting fees to lenders
|
6,519
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(841
|
)
|
|
(5,678
|
)
|
|
—
|
|
||||||||||
|
Mandatory trigger event exit fees
|
55,200
|
|
|
—
|
|
|
3,952
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,314
|
)
|
|
(51,838
|
)
|
|
—
|
|
||||||||||
|
Other issuance costs
|
3,600
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(465
|
)
|
|
(3,135
|
)
|
|
—
|
|
||||||||||
|
Total DDIC
|
89,618
|
|
|
—
|
|
|
3,952
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(11,756
|
)
|
|
(81,814
|
)
|
|
—
|
|
||||||||||
|
Cumulative accretion
|
(30,128
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(11,670
|
)
|
|
4,587
|
|
|
37,211
|
|
|
—
|
|
||||||||||
|
Net discount
|
59,490
|
|
|
—
|
|
|
3,952
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(11,670
|
)
|
|
(7,169
|
)
|
|
(44,603
|
)
|
|
—
|
|
||||||||||
|
Net carrying value
|
$
|
80,054
|
|
|
$
|
1,886
|
|
|
$
|
—
|
|
|
$
|
(9,250
|
)
|
|
$
|
(17,932
|
)
|
|
$
|
(118,200
|
)
|
|
$
|
11,670
|
|
|
$
|
7,169
|
|
|
$
|
44,603
|
|
|
$
|
—
|
|
|
|
December 31, 2016
|
|
PIK Accrual
|
|
Liability Adjustments
|
|
Contractual Liability Payments
|
|
|
|
Amendment Costs
|
|
Accretion Expense
|
|
DDIC
|
|
December 31, 2017
|
||||||||||||||||||||||
|
|
|
|
|
Scheduled
|
|
Prepayments
|
|
Transfers
(1)
|
|
|
|
Write-off
|
|
||||||||||||||||||||||||||
|
Contractual liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Principal balance
|
$
|
107,900
|
|
|
$
|
2,966
|
|
|
$
|
—
|
|
|
$
|
(13,500
|
)
|
|
$
|
(21,494
|
)
|
|
$
|
50,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
125,872
|
|
|
Mandatory trigger event exit fees
|
55,258
|
|
|
—
|
|
|
9,414
|
|
|
—
|
|
|
(5,000
|
)
|
|
(50,000
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,672
|
|
||||||||||
|
Mandatory consulting fees
|
6,000
|
|
|
—
|
|
|
—
|
|
|
(2,000
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,000
|
|
||||||||||
|
Total contractual liabilities
|
169,158
|
|
|
2,966
|
|
|
9,414
|
|
|
(15,500
|
)
|
|
(26,494
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
139,544
|
|
||||||||||
|
DDIC:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Original issue discount
|
2,150
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(334
|
)
|
|
1,816
|
|
||||||||||
|
Origination fee
|
5,375
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(837
|
)
|
|
4,538
|
|
||||||||||
|
Amendment fee
|
8,600
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,300
|
|
|
—
|
|
|
(1,379
|
)
|
|
11,521
|
|
||||||||||
|
Fair value of warrants
|
7,608
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,184
|
)
|
|
6,424
|
|
||||||||||
|
Consulting fees to lenders
|
7,720
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,201
|
)
|
|
6,519
|
|
||||||||||
|
Mandatory trigger event exit fees
|
55,258
|
|
|
—
|
|
|
9,414
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,472
|
)
|
|
55,200
|
|
||||||||||
|
Other issuance costs
|
3,823
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
385
|
|
|
—
|
|
|
(608
|
)
|
|
3,600
|
|
||||||||||
|
Total DDIC
|
90,534
|
|
|
—
|
|
|
9,414
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,685
|
|
|
—
|
|
|
(15,015
|
)
|
|
89,618
|
|
||||||||||
|
Cumulative accretion
|
(9,440
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(23,632
|
)
|
|
2,944
|
|
|
(30,128
|
)
|
||||||||||
|
Net discount
|
81,094
|
|
|
—
|
|
|
9,414
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,685
|
|
|
(23,632
|
)
|
|
(12,071
|
)
|
|
59,490
|
|
||||||||||
|
Net carrying value
|
$
|
88,064
|
|
|
$
|
2,966
|
|
|
$
|
—
|
|
|
$
|
(15,500
|
)
|
|
$
|
(26,494
|
)
|
|
$
|
—
|
|
|
$
|
(4,685
|
)
|
|
$
|
23,632
|
|
|
$
|
12,071
|
|
|
$
|
80,054
|
|
|
(1)
|
Represents the transfer of contractual obligations from mandatory Trigger Event exit fees to principal as required by the Sixth Amendment to the Credit Facility entered into in October 2017.
|
|
|
|
December 31, 2016
|
|
Additions
|
|
Amortization
Expense |
|
December 31, 2017
|
|
Amortization
Expense |
|
DDIC Write-off
|
|
December 31, 2018
|
||||||||||||||
|
Origination fee
|
|
$
|
875
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
875
|
|
|
$
|
—
|
|
|
$
|
(875
|
)
|
|
$
|
—
|
|
|
Amendment fee
|
|
1,400
|
|
|
700
|
|
|
—
|
|
|
2,100
|
|
|
—
|
|
|
(2,100
|
)
|
|
—
|
|
|||||||
|
Fair value of warrants
|
|
1,239
|
|
|
—
|
|
|
—
|
|
|
1,239
|
|
|
—
|
|
|
(1,239
|
)
|
|
—
|
|
|||||||
|
Consulting fees to lenders
|
|
280
|
|
|
—
|
|
|
—
|
|
|
280
|
|
|
—
|
|
|
(280
|
)
|
|
—
|
|
|||||||
|
Other issuance costs
|
|
589
|
|
|
60
|
|
|
—
|
|
|
649
|
|
|
—
|
|
|
(649
|
)
|
|
—
|
|
|||||||
|
Total deferred debt issuance costs
|
|
4,383
|
|
|
760
|
|
|
—
|
|
|
5,143
|
|
|
—
|
|
|
(5,143
|
)
|
|
—
|
|
|||||||
|
Cumulative amortization, net
|
|
(433
|
)
|
|
—
|
|
|
(1,190
|
)
|
|
(1,623
|
)
|
|
(756
|
)
|
|
2,379
|
|
|
—
|
|
|||||||
|
Deferred debt issuance costs, net
|
|
$
|
3,950
|
|
|
$
|
760
|
|
|
$
|
(1,190
|
)
|
|
$
|
3,520
|
|
|
$
|
(756
|
)
|
|
$
|
(2,764
|
)
|
|
$
|
—
|
|
|
•
|
Various financial covenants were revised to provide greater flexibility to promote new business development.
|
|
•
|
Principal payments of
$6.75 million
that would have been payable during the fourth quarter of 2017 were eliminated until maturity. For the six months ending June 30, 2018, principal payments were reduced from
$2.25 million
per month to
$1.0 million
per month. Beginning in July 2018 and continuing through maturity of the Credit Facility, principal payments were reduced from
$2.5 million
per month to
$1.25 million
per month.
|
|
•
|
The Sixth Amendment capped aggregate cash payments for transaction costs and deferred underwriting fees related to the Merger Agreement at
$20.0 million
. The actual cash payments were
$19.8 million
, consisting of
$7.9 million
related to GPIA and
$11.9 million
related to RSI.
|
|
•
|
The unfunded portion of the Credit Facility for
$17.5 million
remained available for potential borrowings through the maturity date with the consent of the Origination Agent.
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Credit Facility:
|
|
|
|
|
|
|
|
|
|||
|
Interest expense at 12.0%
|
$
|
7,513
|
|
|
$
|
11,954
|
|
|
$
|
3,597
|
|
|
PIK interest at 3.0%
|
1,886
|
|
|
2,966
|
|
|
900
|
|
|||
|
Accretion expense for funded debt
|
11,670
|
|
|
23,632
|
|
|
8,371
|
|
|||
|
Make-whole applicable premium:
|
|
|
|
|
|
||||||
|
Credit Facility prepayments
|
3,103
|
|
|
4,607
|
|
|
—
|
|
|||
|
Payoff of funded Credit Facility
|
7,307
|
|
|
—
|
|
|
—
|
|
|||
|
Accretion expense for GP Sponsor note payable
|
905
|
|
|
68
|
|
|
—
|
|
|||
|
Interest on other borrowings
|
146
|
|
|
130
|
|
|
488
|
|
|||
|
Total interest expense
|
$
|
32,530
|
|
|
$
|
43,357
|
|
|
$
|
13,356
|
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Write-off of DDIC:
|
|
|
|
|
|
|
|||||
|
Credit Facility prepayments
|
$
|
7,169
|
|
|
$
|
12,071
|
|
|
$
|
—
|
|
|
Payoff of funded Credit Facility
|
44,603
|
|
|
—
|
|
|
—
|
|
|||
|
Termination of unfunded Credit Facility
|
2,764
|
|
|
—
|
|
|
—
|
|
|||
|
Collateral monitoring fees
|
1,556
|
|
|
2,505
|
|
|
538
|
|
|||
|
Penalty under Credit Facility for delay in closing of Mergers
|
—
|
|
|
1,250
|
|
|
—
|
|
|||
|
Amortization of debt issuance costs related to unfunded debt
|
756
|
|
|
1,190
|
|
|
1,502
|
|
|||
|
Unused line fees
|
481
|
|
|
893
|
|
|
4,095
|
|
|||
|
Amortization of prepaid agent fees and other
|
1,002
|
|
|
452
|
|
|
237
|
|
|||
|
Total debt financing expenses
|
$
|
58,331
|
|
|
$
|
18,361
|
|
|
$
|
6,372
|
|
|
|
Series A Preferred Stock
|
|
Common
|
|
Convertible
|
|
|
|||||||||||
|
|
Shares
|
|
Amount
|
|
Stock
|
|
Notes
|
|
Total
|
|||||||||
|
Fair value on Closing Date:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Series A Preferred Stock
|
140,000
|
|
|
$
|
126,763
|
|
(1)
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
126,763
|
|
|
Common Stock
|
—
|
|
|
—
|
|
|
20,131
|
|
(2)
|
—
|
|
|
20,131
|
|
||||
|
Convertible Notes
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total
|
140,000
|
|
|
$
|
126,763
|
|
|
$
|
20,131
|
|
|
$
|
—
|
|
|
$
|
146,894
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Pro rata allocation of fair value on Closing Date:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Aggregate cash proceeds on Closing Date
|
140,000
|
|
|
$
|
114,773
|
|
(3)
|
$
|
18,227
|
|
(3)
|
$
|
—
|
|
|
$
|
133,000
|
|
|
Incremental and direct costs
|
—
|
|
|
(3,994
|
)
|
(4)
|
(634
|
)
|
(4)
|
—
|
|
|
(4,628
|
)
|
||||
|
Net carrying value on Closing Date
|
140,000
|
|
|
110,779
|
|
|
$
|
17,593
|
|
|
$
|
—
|
|
|
$
|
128,372
|
|
|
|
Accretion of discount through December 31, 2018
|
—
|
|
|
2,373
|
|
(5)
|
|
|
|
|
|
|||||||
|
Issuance of shares to settle PIK Dividends
|
846
|
|
|
846
|
|
(6)
|
|
|
|
|
|
|||||||
|
Net carrying value as of December 31, 2018
|
140,846
|
|
|
$
|
113,998
|
|
|
|
|
|
|
|
||||||
|
(1)
|
The liquidation preference for each share of Series A Preferred Stock on the Closing
|
|
(2)
|
Date was
$1,000
per share for an aggregate liquidation preference of
$140.0 million
. The fair value of the Series A Preferred Stock was approximately
$126.8 million
on the Closing Date which is the basis for allocation of the net proceeds. Please refer to Note
13
for further discussion of the valuation methodology employed.
|
|
(3)
|
The fair value of the issuance of approximately
2.9 million
shares of the Common Stock was based on the last closing price of
$6.95
per share prior to closing.
|
|
(4)
|
The aggregate cash proceeds of
$133.0 million
on the Closing Date were allocated pro rata based on the fair value of all consideration issued of
$146.9 million
.
|
|
(5)
|
Incremental and direct costs of the Private Placement were allocated pro rata based on the fair value of all consideration issued of
$146.9 million
. Such costs include financial advisory and professional fees of
$2.7 million
that were incurred by the Company, and due diligence and professional fees incurred by the investors of
$1.9 million
. Of the total incremental and direct costs of
$4.6 million
,
$2.7 million
was paid from the net proceeds at closing and
$1.9 million
was paid directly by the Company.
|
|
(5)
|
The difference between the initial liquidation preference of
$140.0 million
and the initial carrying value shown above of
$110.8 million
on the Closing Date represents a discount of
$29.2 million
that is being accreted at a rate of
4.8%
per annum using the effective interest method. As shown in Note
12
, accretion is treated as a deduction in the calculation of earnings applicable to common stockholders. Accretion was
$2.4 million
for the period from
July 19, 2018
through
December 31, 2018
, which resulted in an increase in the carrying value of the Series A Preferred Stock and a corresponding reduction in additional paid-in capital. As a result of these periodic accretion adjustments, the carrying value of
$110.8 million
related to the original issuance of
140,000
shares of Series A Preferred Stock will continue to increase until it is equal to the
$140.0 million
liquidation preference applicable to such shares on
July 19, 2023
when the holders may first elect to redeem their shares for cash.
|
|
(6)
|
A total of
846
shares of Series A Preferred Stock were issued on
October 1, 2018
to settle accrued PIK Dividends for the third quarter of 2018. These shares had an initial liquidation preference of
$1,000
per share for a total of
$0.8 million
.
|
|
|
|
Dividends Payable in:
|
|
Total Dividends
|
|
Dividends
|
||||||||||
|
|
|
Cash
|
|
PIK
|
|
|
Per Share
|
|||||||||
|
Cash Dividends at 10.0% per annum:
|
|
|
|
|
|
|
|
|
||||||||
|
Third quarter of 2018
|
|
$
|
2,839
|
|
|
$
|
—
|
|
|
$
|
2,839
|
|
|
$
|
20.28
|
|
|
Fourth quarter of 2018
|
|
3,521
|
|
|
—
|
|
|
3,521
|
|
|
25.00
|
|
||||
|
PIK Dividends at 3.0% per annum:
|
|
|
|
|
|
|
|
|
||||||||
|
Third quarter of 2018
|
|
—
|
|
|
846
|
|
|
846
|
|
|
6.04
|
|
||||
|
Fourth quarter of 2018
|
|
—
|
|
|
1,056
|
|
|
1,056
|
|
|
7.50
|
|
||||
|
Fractional shares payable in cash
|
|
6
|
|
|
—
|
|
|
6
|
|
|
0.04
|
|
||||
|
Total dividends accrued in 2018
|
|
6,366
|
|
|
1,902
|
|
|
8,268
|
|
|
58.86
|
|
||||
|
Less dividends paid in 2018
|
|
(2,845
|
)
|
|
(846
|
)
|
|
(3,691
|
)
|
|
(26.36
|
)
|
||||
|
Liability for unpaid dividends, December 31, 2018
|
|
$
|
3,521
|
|
|
$
|
1,056
|
|
|
$
|
4,577
|
|
|
$
|
32.50
|
|
|
RSI Preferred Stock as of December 31, 2016
|
|
Conversion to Common Stock in Mergers
|
||||||||||||||||||||
|
|
|
Number of Shares (1)
|
|
Carrying Value (2)
|
|
Liquidation Preference (3)
|
|
Number of Shares (4)
|
|
Common Stock
|
|
Additional Paid-in Capital
|
||||||||||
|
Series
|
|
|
|
|
|
|
||||||||||||||||
|
A
|
|
5,500
|
|
|
$
|
493
|
|
|
$
|
550
|
|
|
1,317
|
|
|
$
|
—
|
|
|
$
|
493
|
|
|
B
|
|
38,545
|
|
|
9,142
|
|
|
10,000
|
|
|
9,228
|
|
|
1
|
|
|
9,141
|
|
||||
|
C
|
|
56,441
|
|
|
9,907
|
|
|
10,001
|
|
|
13,513
|
|
|
2
|
|
|
9,905
|
|
||||
|
Total
|
|
100,486
|
|
|
$
|
19,542
|
|
|
$
|
20,551
|
|
|
24,058
|
|
|
$
|
3
|
|
|
$
|
19,539
|
|
|
(1)
|
Represents the number of shares of RSI Preferred Stock by series that were authorized, issued and outstanding. Each
issued and outstanding share of RSI Preferred Stock was convertible into
one
share of RSI Common Stock.
|
|
(2)
|
The carrying value for each series of RSI Preferred Stock was net of incremental and direct professional fees and other costs incurred in connection with the original issuance.
|
|
(3)
|
The holders of RSI Preferred Stock were entitled to receive, prior and in preference to the holders of RSI Common Stock, any distribution of the assets of the Company in an amount equal to the respective liquidation preference for each series of RSI Preferred Stock.
|
|
(4)
|
Conversion to shares of RMNI Common Stock upon consummation of the Mergers on
October 10, 2017
is based on the Exchange Ratio as discussed further in Note
3
.
|
|
|
2018
|
|
2017
|
|
2016
|
|||||||||||||||||||||
|
|
Shares
|
|
Price (1)
|
|
Term (2)
|
|
Shares
|
|
Price (1)
|
|
Term (2)
|
|
Shares
|
|
Price (1)
|
|
Term (2)
|
|||||||||
|
Outstanding, beginning of year
|
12,130
|
|
|
$
|
2.95
|
|
|
|
|
12,863
|
|
|
$
|
1.94
|
|
|
|
|
12,639
|
|
|
$
|
1.84
|
|
|
|
|
Granted
|
1,870
|
|
|
7.87
|
|
|
|
|
1,877
|
|
|
7.63
|
|
|
|
|
571
|
|
|
5.79
|
|
|
|
|||
|
Forfeited
|
(69
|
)
|
|
7.96
|
|
|
|
|
(298
|
)
|
|
6.93
|
|
|
|
|
(225
|
)
|
|
5.63
|
|
|
|
|||
|
Expired
|
(45
|
)
|
|
5.96
|
|
|
|
|
(1,093
|
)
|
|
0.55
|
|
|
|
|
(87
|
)
|
|
3.63
|
|
|
|
|||
|
Exercised
|
(1,982
|
)
|
|
1.03
|
|
|
|
|
(1,219
|
)
|
|
0.71
|
|
|
|
|
(35
|
)
|
|
1.41
|
|
|
|
|||
|
Outstanding, end of year
(3)(4)
|
11,904
|
|
|
4.00
|
|
|
5.1
|
|
12,130
|
|
|
2.95
|
|
|
4.9
|
|
12,863
|
|
|
1.94
|
|
|
4.6
|
|||
|
Vested, end of year
(3)
|
9,211
|
|
|
2.91
|
|
|
3.9
|
|
10,033
|
|
|
2.09
|
|
|
4.0
|
|
11,369
|
|
|
1.51
|
|
|
4.1
|
|||
|
(1)
|
Represents the weighted average exercise price.
|
|
(2)
|
Represents the weighted average remaining contractual term until the stock options expire.
|
|
(3)
|
As of
December 31, 2018
,
2017
and
2016
, the aggregate intrinsic value of stock options outstanding was
$23.0 million
,
$60.4 million
, and
$28.7 million
, respectively. As of
December 31, 2018
,
2017
and
2016
, the aggregate intrinsic value of vested stock options was
$23.0 million
,
$58.4 million
and
$28.7 million
, respectively.
|
|
(4)
|
The number of outstanding stock options that are not expected to ultimately vest due to forfeiture amounted to
0.3 million
shares as of
December 31, 2018
.
|
|
|
2018
|
|
2017
|
|
2016
|
|||
|
Available, beginning of year
|
2,413
|
|
|
2,899
|
|
|
1,652
|
|
|
Stock options granted
|
(1,870
|
)
|
|
(1,877
|
)
|
|
(571
|
)
|
|
RSU's granted
|
(199
|
)
|
|
—
|
|
|
—
|
|
|
Expired options under 2007 Plan
|
45
|
|
|
1,093
|
|
|
87
|
|
|
Forfeited options under Stock Plans
|
69
|
|
|
298
|
|
|
225
|
|
|
Newly authorized by Board of Directors
|
2,300
|
|
|
—
|
|
|
1,506
|
|
|
Available, end of year
|
2,758
|
|
|
2,413
|
|
|
2,899
|
|
|
|
2018
|
|
2017
|
|
2016
|
|||
|
Expected life (in years)
|
5.9
|
|
|
5.9
|
|
|
6.0
|
|
|
Volatility
|
31
|
%
|
|
33
|
%
|
|
37
|
%
|
|
Dividend yield
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
Risk-free interest rate
|
2.8
|
%
|
|
1.9
|
%
|
|
1.4
|
%
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Cost of revenues
|
$
|
885
|
|
|
$
|
399
|
|
|
$
|
286
|
|
|
Sales and marketing
|
1,865
|
|
|
1,411
|
|
|
764
|
|
|||
|
General and administrative
|
1,644
|
|
|
1,153
|
|
|
1,247
|
|
|||
|
Total
|
$
|
4,394
|
|
|
$
|
2,963
|
|
|
$
|
2,297
|
|
|
|
|
Issuance Date
|
|
Expiration Date
|
|
Exercise Price
|
|
Number
|
|
|||
|
Description
|
|
|
|
|
of Shares
|
|
||||||
|
Origination Agent Warrant
|
|
October 2017
|
|
June 2026
|
(1)
|
$
|
5.64
|
|
|
3,440
|
|
(2)
|
|
GPIA Public Warrants
|
|
May 2015
|
|
October 2022
|
|
11.50
|
|
|
8,625
|
|
(3)
|
|
|
GP Sponsor Private Placement Warrants
|
|
May 2015
|
|
October 2022
|
|
11.50
|
|
|
6,063
|
|
(4)
|
|
|
Total
|
|
|
|
|
|
|
|
18,128
|
|
|
||
|
(1)
|
The expiration date for the Origination Agent Warrant is the earlier to occur of the stated expiration date or the date when the Company experiences a change of control.
|
|
(2)
|
The Origination Agent Warrant was issued upon consummation of the Mergers discussed in Note
3
and resulted in the elimination of the redemption features associated with two warrants issued in 2016 as discussed below under RSI Redeemable Warrants.
|
|
(3)
|
On May 26, 2015, GPIA completed an initial public offering that included warrants for
8,625,000
shares of Common Stock (the “Public Warrants”). Each Public Warrant entitles the holder to the right to purchase one share of Common Stock at an exercise price of
$11.50
per share. No fractional shares will be issued upon exercise of the Public Warrants. The Company may elect to redeem the Public Warrants, in whole or in part, at a price of
$0.01
per Public Warrant if (i) 30 days’ prior written notice is provided to the holders, and (ii) the last sale price of the Company’s Common Stock equals or exceeds
$18.00
per share for any
20
trading days within a
30
-trading day period ending on the third trading day prior to the date on which the notice of redemption is sent to the Public Warrant holders. Upon issuance of a redemption notice by the Company, the warrant holders have a period of 30 days to exercise for cash, or on a cashless basis.
|
|
(4)
|
Simultaneously with GPIA’s initial public offering in May 2015, GP Sponsor purchased an aggregate of
6,062,500
warrants at a purchase price of
$1.00
per warrant in a private placement (the “Private Placement Warrants”). The Private Placement Warrants may not be redeemed by the Company so long as the Private Placement Warrants are held by the initial purchasers, or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or such purchasers’ permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
|
|
|
|
|
|
|
|
Loss (Gain) From Changes in Fair Value
(1)
|
|
Liability at December 31, 2016
|
|
Loss From Changes in Fair Value
(1)
|
|
Liability at October 10, 2017
|
|
|||||||||||
|
RSI Redeemable Warrants
|
|
Number of Shares
|
|
Value at Issuance
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Original Warrant
|
|
2,651
|
|
|
$
|
8,847
|
|
(2)
|
$
|
(3,142
|
)
|
(3)
|
$
|
5,705
|
|
|
$
|
12,833
|
|
(4)
|
$
|
18,538
|
|
(5)
|
|
Anti-Dilution Warrant
|
|
727
|
|
|
1,484
|
|
(3)
|
80
|
|
(3)
|
1,564
|
|
|
3,519
|
|
(4)
|
5,083
|
|
(5)
|
|||||
|
Total
|
|
3,378
|
|
|
$
|
10,331
|
|
|
$
|
(3,062
|
)
|
|
$
|
7,269
|
|
|
$
|
16,352
|
|
|
$
|
23,621
|
|
(5)
|
|
(1)
|
The RSI Redeemable Warrants were classified within Level 3 of the fair value hierarchy. Valuation of the warrants was performed by an independent valuation specialist at the original issuance dates and on a quarterly basis through September 30, 2017. The valuation methodology was performed through a hybrid model using Monte Carlo simulation, which considered possible future equity financing and liquidity scenarios, including an initial public offering, a sale of the business, and a liquidation of the Company. Key Level 3 assumptions inherent in the warrant valuation methodology as of September 30, 2017 include projected revenue multiples of
1.7
to
1.8
, volatility of
46%
to
48%
, the risk-free interest rate of
1.1%
to
1.5%
, a discount rate for lack of marketability of
6%
, and the overall discount rate of approximately
20%
. The valuation methodology as of October 10, 2017 only considered the scenario for consummation of the Mergers based on the agreed upon price of
$10.00
per share of Common Stock, volatility of
48%
, the risk-free interest rate of
1.1%
, and the overall discount rate of approximately
20%
. Key Level 3 assumptions inherent in the valuation methodology as of
December 31, 2016
include projected revenue multiples ranging from
1.7
to
2.0
, volatility ranging from
44%
to
65%
, the risk-free interest rate ranging from
0.5%
to
1.4%
, a discount rate for lack of marketability ranging from
26%
to
31%
, and the overall discount rate of approximately
25%
.
|
|
(2)
|
As discussed in Note
5
, the original fair value of the Original Warrant to purchase approximately
2.7 million
shares of the Company’s Common Stock was
$8.8 million
which was accounted for as DDIC in
June 2016
.
|
|
(3)
|
The fair value of the Anti-Dilution Warrant and other changes in fair value from the issuance date through
December 31, 2016
, were recognized as a loss on change in fair value of redeemable warrants in the accompanying consolidated statement of operations and comprehensive loss for the year ended
December 31, 2016
.
|
|
(4)
|
Changes in fair value from
December 31, 2016
through
October 10, 2017
, were recognized as a loss on change in fair value of redeemable warrants in the accompanying consolidated statement of operations and comprehensive loss for the year ended
December 31, 2017
.
|
|
(5)
|
As discussed above, the cash redemption feature associated with the RSI Redeemable Warrants was eliminated effective on
October 10, 2017
. Accordingly, the fair value of the RSI Redeemable Warrants in the aggregate amount of
$23.6 million
was reclassified to additional paid-in capital immediately prior to consummation of the Mergers.
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Domestic
|
$
|
(72,235
|
)
|
|
$
|
(56,268
|
)
|
|
$
|
(14,644
|
)
|
|
International
|
6,262
|
|
|
4,290
|
|
|
3,239
|
|
|||
|
|
$
|
(65,973
|
)
|
|
$
|
(51,978
|
)
|
|
$
|
(11,405
|
)
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Income tax benefit at statutory U.S. federal rate
|
$
|
13,854
|
|
|
$
|
17,673
|
|
|
$
|
3,877
|
|
|
Income tax benefit attributable to U.S. states, net
|
(362
|
)
|
|
1,469
|
|
|
380
|
|
|||
|
Permanent differences:
|
|
|
|
|
|
||||||
|
Non-deductible expenses
|
(247
|
)
|
|
(284
|
)
|
|
(301
|
)
|
|||
|
Stock-based compensation
|
918
|
|
|
(862
|
)
|
|
(299
|
)
|
|||
|
Other
|
(24
|
)
|
|
(215
|
)
|
|
(256
|
)
|
|||
|
Global intangible low taxed income
|
(1,027
|
)
|
|
—
|
|
|
—
|
|
|||
|
Change in statutory federal tax rate
|
—
|
|
|
(31,826
|
)
|
|
—
|
|
|||
|
Transition tax
|
—
|
|
|
(1,503
|
)
|
|
—
|
|
|||
|
Foreign rate differential and foreign tax credits
|
(511
|
)
|
|
522
|
|
|
(211
|
)
|
|||
|
Reclassification of warrant to equity and other
|
69
|
|
|
(8,828
|
)
|
|
1,421
|
|
|||
|
(Increase) decrease in valuation allowance
|
(14,662
|
)
|
|
22,535
|
|
|
(6,143
|
)
|
|||
|
Total income tax expense
|
$
|
(1,992
|
)
|
|
$
|
(1,319
|
)
|
|
$
|
(1,532
|
)
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Current income tax expense:
|
|
|
|
|
|
|
|
|
|||
|
Federal
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
State
|
(112
|
)
|
|
(140
|
)
|
|
(98
|
)
|
|||
|
Foreign
|
(2,115
|
)
|
|
(1,303
|
)
|
|
(1,954
|
)
|
|||
|
Total current income tax expense
|
(2,227
|
)
|
|
(1,443
|
)
|
|
(2,052
|
)
|
|||
|
Deferred income tax benefit:
|
|
|
|
|
|
|
|
|
|||
|
Federal
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
State
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Foreign
|
235
|
|
|
124
|
|
|
520
|
|
|||
|
Total deferred income tax benefit
|
235
|
|
|
124
|
|
|
520
|
|
|||
|
Total income tax expense
|
$
|
(1,992
|
)
|
|
$
|
(1,319
|
)
|
|
$
|
(1,532
|
)
|
|
|
2018
|
|
2017
|
||||
|
Deferred income tax assets:
|
|
|
|
|
|
||
|
Net operating loss carryforwards
|
$
|
45,639
|
|
|
$
|
45,032
|
|
|
Deferred revenue
|
6,635
|
|
|
7,907
|
|
||
|
Accounts payable and accrued expenses
|
2,499
|
|
|
6,355
|
|
||
|
Debt financing interest and fees
|
—
|
|
|
4,712
|
|
||
|
Stock-based compensation
|
1,539
|
|
|
1,286
|
|
||
|
Capital loss carryforwards
|
1,288
|
|
|
1,439
|
|
||
|
Tax credit carryforwards
|
423
|
|
|
571
|
|
||
|
Deferred rent and other
|
1,529
|
|
|
401
|
|
||
|
Embedded derivative liability
|
—
|
|
|
425
|
|
||
|
Foreign deferred assets
|
1,357
|
|
|
1,263
|
|
||
|
Business interest carryforwards
|
22,946
|
|
|
—
|
|
||
|
Gross deferred income tax assets
|
83,855
|
|
|
69,391
|
|
||
|
Valuation allowance for deferred income tax assets
|
(82,905
|
)
|
|
(68,367
|
)
|
||
|
Net deferred income tax assets
|
950
|
|
|
1,024
|
|
||
|
Deferred income tax liabilities:
|
|
|
|
||||
|
Other
|
(41
|
)
|
|
(305
|
)
|
||
|
Deferred tax assets, net
|
$
|
909
|
|
|
$
|
719
|
|
|
Year ending December 31:
|
|
||
|
2019
|
$
|
4,942
|
|
|
2020
|
4,058
|
|
|
|
2021
|
3,765
|
|
|
|
2022
|
2,936
|
|
|
|
2023
|
370
|
|
|
|
Thereafter
|
349
|
|
|
|
Total
|
$
|
16,420
|
|
|
Year ending December 31:
|
|
||
|
2019
|
$
|
414
|
|
|
2020
|
155
|
|
|
|
2021
|
72
|
|
|
|
Total minimum lease payments
|
641
|
|
|
|
Less amounts representing interest
|
40
|
|
|
|
Present value of minimum lease payments
|
601
|
|
|
|
Less current portion, included in accrued expenses
|
387
|
|
|
|
Long term obligation, included in other long-term liabilities
|
$
|
214
|
|
|
|
2018
|
|
2017
|
||||
|
Leased computer equipment
|
$
|
3,109
|
|
|
$
|
2,722
|
|
|
Less accumulated depreciation
|
(2,346
|
)
|
|
(1,744
|
)
|
||
|
Net
|
$
|
763
|
|
|
$
|
978
|
|
|
Year Ending December 31:
|
|
Cash
|
|
PIK
|
|
Total
|
||||||
|
2019
|
|
$
|
14,351
|
|
(1)
|
$
|
4,305
|
|
(1)
|
$
|
18,656
|
|
|
2020
|
|
14,787
|
|
(1)
|
4,436
|
|
(1)
|
19,223
|
|
|||
|
2021
|
|
15,235
|
|
(1)
|
4,571
|
|
(1)
|
19,806
|
|
|||
|
2022
|
|
15,698
|
|
(1)
|
4,709
|
|
(1)
|
20,407
|
|
|||
|
2023
|
|
8,838
|
|
(1)
|
2,652
|
|
(1)
|
11,490
|
|
|||
|
Total
|
|
$
|
68,909
|
|
|
$
|
20,673
|
|
|
$
|
89,582
|
|
|
(1)
|
Amounts shown assume there are no conversions to Common Stock or redemptions for the initial five-year period through
July 19, 2023
.
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Loss attributable to common stockholders:
|
|
|
|
|
|
||||||
|
Net loss
|
$
|
(67,965
|
)
|
|
$
|
(53,297
|
)
|
|
$
|
(12,937
|
)
|
|
Dividends and accretion related to Series A Preferred Stock:
|
|
|
|
|
|
||||||
|
Cash dividends declared
|
(6,366
|
)
|
|
—
|
|
|
—
|
|
|||
|
PIK dividends declared
|
(1,902
|
)
|
|
—
|
|
|
—
|
|
|||
|
Accretion of discount
|
(2,373
|
)
|
|
—
|
|
|
—
|
|
|||
|
Deemed dividend for RSI Preferred Stock
|
—
|
|
|
—
|
|
|
(10,000
|
)
|
|||
|
Loss attributable to common stockholders
|
$
|
(78,606
|
)
|
|
$
|
(53,297
|
)
|
|
$
|
(22,937
|
)
|
|
|
|
|
|
|
|
||||||
|
Weighted average number of shares of Common Stock outstanding (basic and diluted)
|
61,384
|
|
|
32,229
|
|
|
24,262
|
|
|||
|
Net loss per share attributable to Common Stock (basic and diluted)
|
$
|
(1.28
|
)
|
|
$
|
(1.65
|
)
|
|
$
|
(0.95
|
)
|
|
|
2018
|
|
2017
|
|
2016
|
|||
|
Warrants
|
18,128
|
|
|
18,128
|
|
|
3,461
|
|
|
Series A Preferred Stock
|
14,085
|
|
|
—
|
|
|
—
|
|
|
Stock options
|
11,904
|
|
|
12,130
|
|
|
12,863
|
|
|
Restricted stock units
|
199
|
|
|
—
|
|
|
—
|
|
|
RSI Preferred Stock
|
—
|
|
|
—
|
|
|
24,058
|
|
|
Total
|
44,316
|
|
|
30,258
|
|
|
40,382
|
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
United States of America
|
$
|
163,219
|
|
|
$
|
144,019
|
|
|
$
|
110,746
|
|
|
International
|
89,571
|
|
|
68,614
|
|
|
49,429
|
|
|||
|
Total revenue
|
$
|
252,790
|
|
|
$
|
212,633
|
|
|
$
|
160,175
|
|
|
|
2018
|
|
2017
|
|
||||||||||||||||||||||||||||
|
|
Q1
|
|
Q2
|
|
Q3
|
|
Q4
|
|
Q1
|
|
Q2
|
|
Q3
|
|
Q4
|
|
||||||||||||||||
|
Revenue
|
$
|
59,805
|
|
|
$
|
62,649
|
|
|
$
|
62,629
|
|
|
$
|
67,707
|
|
|
$
|
49,070
|
|
|
$
|
52,048
|
|
|
$
|
53,611
|
|
|
$
|
57,904
|
|
|
|
Cost of revenue
|
23,541
|
|
|
26,084
|
|
|
22,220
|
|
|
24,136
|
|
|
18,356
|
|
|
19,537
|
|
|
20,109
|
|
|
24,896
|
|
|
||||||||
|
Gross profit
|
36,264
|
|
|
36,565
|
|
|
40,409
|
|
|
43,571
|
|
|
30,714
|
|
|
32,511
|
|
|
33,502
|
|
|
33,008
|
|
|
||||||||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Sales and marketing
|
20,207
|
|
|
23,097
|
|
|
22,312
|
|
|
27,599
|
|
|
14,696
|
|
|
15,801
|
|
|
17,188
|
|
|
19,074
|
|
|
||||||||
|
General and administrative
|
10,805
|
|
|
10,324
|
|
|
8,585
|
|
|
7,268
|
|
|
9,276
|
|
|
8,928
|
|
|
8,580
|
|
|
9,360
|
|
|
||||||||
|
Litigation costs, net of recoveries
|
(19,969
|
)
|
|
9,113
|
|
|
6,990
|
|
|
5,124
|
|
|
3,945
|
|
|
301
|
|
|
365
|
|
|
249
|
|
|
||||||||
|
Total operating expenses
|
11,043
|
|
|
42,534
|
|
|
37,887
|
|
|
39,991
|
|
|
27,917
|
|
|
25,030
|
|
|
26,133
|
|
|
28,683
|
|
|
||||||||
|
Operating income (loss)
|
25,221
|
|
|
(5,969
|
)
|
|
2,522
|
|
|
3,580
|
|
|
2,797
|
|
|
7,481
|
|
|
7,369
|
|
|
4,325
|
|
|
||||||||
|
Interest expense
|
(13,409
|
)
|
|
(9,323
|
)
|
|
(9,499
|
)
|
|
(299
|
)
|
|
(9,936
|
)
|
|
(14,541
|
)
|
|
(9,152
|
)
|
|
(9,728
|
)
|
|
||||||||
|
Other debt financing expenses
|
(8,617
|
)
|
|
(1,339
|
)
|
|
(48,375
|
)
|
|
—
|
|
|
(1,282
|
)
|
|
(10,859
|
)
|
|
(2,563
|
)
|
|
(3,657
|
)
|
|
||||||||
|
Gain (loss) on change in fair value of redeemable warrants
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(602
|
)
|
|
(7,648
|
)
|
|
(5,817
|
)
|
|
(2,285
|
)
|
|
||||||||
|
Gain (loss) on change in fair value of embedded derivatives
|
500
|
|
|
(6,700
|
)
|
|
7,800
|
|
|
—
|
|
|
(5,100
|
)
|
|
(700
|
)
|
|
1,400
|
|
|
8,200
|
|
|
||||||||
|
Other income (expense), net
|
328
|
|
|
(1,568
|
)
|
|
(306
|
)
|
|
(520
|
)
|
|
89
|
|
|
225
|
|
|
108
|
|
|
(102
|
)
|
|
||||||||
|
Income (loss) before income taxes
|
4,023
|
|
|
(24,899
|
)
|
|
(47,858
|
)
|
|
2,761
|
|
|
(14,034
|
)
|
|
(26,042
|
)
|
|
(8,655
|
)
|
|
(3,247
|
)
|
|
||||||||
|
Income tax expense
|
(516
|
)
|
|
(547
|
)
|
|
(510
|
)
|
|
(419
|
)
|
|
(441
|
)
|
|
183
|
|
|
(385
|
)
|
|
(676
|
)
|
|
||||||||
|
Net income (loss)
|
$
|
3,507
|
|
|
$
|
(25,446
|
)
|
|
$
|
(48,368
|
)
|
|
$
|
2,342
|
|
|
$
|
(14,475
|
)
|
|
$
|
(25,859
|
)
|
|
$
|
(9,040
|
)
|
|
$
|
(3,923
|
)
|
|
|
Net loss attributable to common stockholders
(1)
|
$
|
3,507
|
|
|
$
|
(25,446
|
)
|
|
$
|
(53,070
|
)
|
|
$
|
(3,597
|
)
|
|
$
|
(14,475
|
)
|
|
$
|
(25,859
|
)
|
|
$
|
(9,040
|
)
|
|
$
|
(3,923
|
)
|
|
|
Earnings (loss) per share attributable to common stockholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Basic
(2) (3)
|
$
|
0.06
|
|
|
$
|
(0.43
|
)
|
|
$
|
(0.85
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.59
|
)
|
|
$
|
(1.05
|
)
|
|
$
|
(0.37
|
)
|
|
$
|
(0.07
|
)
|
|
|
Diluted
(2) (3)
|
$
|
0.05
|
|
|
$
|
(0.43
|
)
|
|
$
|
(0.85
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.59
|
)
|
|
$
|
(1.05
|
)
|
|
$
|
(0.37
|
)
|
|
$
|
(0.07
|
)
|
|
|
Weighted average number of common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Basic
(2)
|
59,393
|
|
|
59,800
|
|
|
62,590
|
|
|
63,817
|
|
|
24,353
|
|
|
24,561
|
|
|
24,727
|
|
|
55,021
|
|
|
||||||||
|
Diluted
(2)
|
68,154
|
|
|
59,800
|
|
|
62,590
|
|
|
63,817
|
|
|
24,353
|
|
|
24,561
|
|
|
24,727
|
|
|
55,021
|
|
|
||||||||
|
(1)
|
Beginning in the third quarter of 2018, amount consists of net loss less dividends and accretion of discount related to Series A Preferred Stock discussed in Note
6
.
|
|
(2)
|
For each quarter in 2017, weighted average number of shares has been retroactively restated to give effect to the reverse recapitalization discussed in Note
1
.
|
|
(3)
|
Quarterly amounts may not sum to annual amounts due to rounding and the nature of the calculations.
|
|
•
|
may have been qualified by disclosures that were made to the other parties in connection with the negotiation of the agreements, which disclosures are not necessarily reflected in the agreements;
|
|
•
|
may apply standards of materiality that differ from those of a reasonable investor; and
|
|
•
|
were made only as of specified dates contained in the agreements and are subject to subsequent developments and changed circumstances.
|
|
|
|
|
|
Incorporated by Reference
|
||||||
|
Exhibit
Number
|
|
Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
2.1*
|
|
|
8-K
|
|
001-37397
|
|
2.1
|
|
May 17, 2017
|
|
|
2.2*
|
|
|
8-K
|
|
001-37397
|
|
2.1
|
|
June 30, 2017
|
|
|
3.1*
|
|
|
8-K
|
|
001-37397
|
|
3.1
|
|
October 16, 2017
|
|
|
3.2*
|
|
|
8-K
|
|
001-37397
|
|
3.2
|
|
October 16, 2017
|
|
|
3.3*
|
|
|
8-K
|
|
001-37397
|
|
3.1
|
|
July 19, 2018
|
|
|
4.1*
|
|
|
S-4
|
|
333-219101
|
|
4.5
|
|
June 30, 2017
|
|
|
4.2*
|
|
|
S-1
|
|
333-203500
|
|
4.3
|
|
April 17, 2015
|
|
|
4.3*
|
|
|
8-K
|
|
001-37397
|
|
4.1
|
|
June 1, 2015
|
|
|
4.4*
|
|
|
8-K
|
|
001-37397
|
|
10.2
|
|
June 1, 2015
|
|
|
4.5*
|
|
|
8-K
|
|
001-37397
|
|
10.3
|
|
June 1, 2015
|
|
|
4.6*
|
|
|
S-4
|
|
333-219101
|
|
4.8
|
|
June 30, 2017
|
|
|
4.7*
|
|
|
S-4/A
|
|
333-219101
|
|
10.51
|
|
August 9, 2017
|
|
|
4.8*
|
|
|
8-K
|
|
001-37397
|
|
10.1
|
|
June 18, 2018
|
|
|
4.9*
|
|
|
8-K
|
|
001-37397
|
|
10.1
|
|
July 19, 2018
|
|
|
4.10*
|
|
|
Schedule 14A
|
|
001-37397
|
|
Annex D
|
|
July 2, 2018
|
|
|
4.11*
|
|
|
8-K
|
|
001-37397
|
|
10.3
|
|
July 19, 2018
|
|
|
4.12*
|
|
|
8-K
|
|
001-37397
|
|
10.1
|
|
March 11, 2019
|
|
|
4.13*
|
|
|
8-K
|
|
001-37397
|
|
10.2
|
|
March 11, 2019
|
|
|
4.14*
|
|
|
8-K
|
—
|
001-37397
|
|
10.3
|
|
March 11, 2019
|
|
|
4.15*
|
|
|
8-K
|
|
001-37397
|
|
10.4
|
|
March 11, 2019
|
|
|
10.1*
|
|
|
8-K
|
|
001-37397
|
|
10.1
|
|
October 16, 2017
|
|
|
10.2*†
|
|
|
S-4
|
|
333-219101
|
|
10.19
|
|
June 30, 2017
|
|
|
10.3*†
|
|
|
S-4/A
|
|
333-219101
|
|
10.20
|
|
August 9, 2017
|
|
|
10.4*†
|
|
|
S-4/A
|
|
333-219101
|
|
10.52
|
|
August 9, 2017
|
|
|
10.5*†
|
|
|
S-4
|
|
333-219101
|
|
10.21
|
|
June 30, 2017
|
|
|
10.6*†
|
|
|
S-4
|
|
333-219101
|
|
10.22
|
|
June 30, 2017
|
|
|
10.7*†
|
|
|
S-4
|
|
333-219101
|
|
10.23
|
|
June 30, 2017
|
|
|
10.8*†
|
|
|
S-4
|
|
333-219101
|
|
10.24
|
|
June 30, 2017
|
|
|
10.9*†
|
|
|
S-4
|
|
333-219101
|
|
10.25
|
|
June 30, 2017
|
|
|
10.10+†
|
|
|
|
|
|
|
|
|
|
|
|
10.11*†
|
|
|
10-Q
|
|
333-219101
|
|
10.10
|
|
May 10, 2018
|
|
|
10.12+†
|
|
|
|
|
|
|
|
|
|
|
|
10.13+†
|
|
|
|
|
|
|
|
|
|
|
|
10.14*
|
|
|
S-4
|
|
333-219101
|
|
10.26
|
|
June 30, 2017
|
|
|
10.15*
|
|
|
S-4
|
|
333-219101
|
|
10.27
|
|
June 30, 2017
|
|
|
10.16*
|
|
|
S-4
|
|
333-219101
|
|
10.28
|
|
June 30, 2017
|
|
|
10.17*
|
|
|
S-4
|
|
333-219101
|
|
10.29
|
|
June 30, 2017
|
|
|
10.18*
|
|
|
S-4
|
|
333-219101
|
|
10.30
|
|
June 30, 2017
|
|
|
10.19*
|
|
|
S-4
|
|
333-219101
|
|
10.31
|
|
June 30, 2017
|
|
|
10.20*
|
|
|
8-K
|
|
001-37397
|
|
99.1
|
|
October 4, 2017
|
|
|
10.21*
|
|
|
S-4
|
|
333-219101
|
|
10.32
|
|
June 30, 2017
|
|
|
10.22*
|
|
|
S-4
|
|
333-219101
|
|
10.33
|
|
June 30, 2017
|
|
|
10.23*
|
|
|
S-4
|
|
333-219101
|
|
10.34
|
|
June 30, 2017
|
|
|
10.24*
|
|
|
8-K
|
|
001-37397
|
|
99.4
|
|
October 4, 2017
|
|
|
10.25*
|
|
|
S-4
|
|
333-219101
|
|
10.35
|
|
June 30, 2017
|
|
|
10.26*
|
|
|
S-4
|
|
333-219101
|
|
10.36
|
|
June 30, 2017
|
|
|
10.27*
|
|
|
S-4
|
|
333-219101
|
|
10.37
|
|
June 30, 2017
|
|
|
10.28*
|
|
|
8-K
|
|
001-37397
|
|
99.3
|
|
October 4, 2017
|
|
|
10.29*
|
|
|
S-4
|
|
333-219101
|
|
10.38
|
|
June 30, 2017
|
|
|
10.30*
|
|
|
S-4
|
|
333-219101
|
|
10.39
|
|
June 30, 2017
|
|
|
10.31*
|
|
|
S-4
|
|
333-219101
|
|
10.40
|
|
June 30, 2017
|
|
|
10.32*
|
|
|
S-4
|
|
333-219101
|
|
10.41
|
|
June 30, 2017
|
|
|
10.33*
|
|
|
S-4
|
|
333-219101
|
|
10.42
|
|
June 30, 2017
|
|
|
10.34*
|
|
|
S-4
|
|
333-219101
|
|
10.43
|
|
June 30, 2017
|
|
|
10.35*
|
|
|
S-4
|
|
333-219101
|
|
10.44
|
|
June 30, 2017
|
|
|
10.36*
|
|
|
S-4
|
|
333-219101
|
|
10.45
|
|
June 30, 2017
|
|
|
10.37*
|
|
|
S-4
|
|
333-219101
|
|
10.46
|
|
June 30, 2017
|
|
|
10.38*
|
|
|
S-4
|
|
333-219101
|
|
10.47
|
|
June 30, 2017
|
|
|
10.39*
|
|
|
S-4
|
|
333-219101
|
|
10.48
|
|
June 30, 2017
|
|
|
10.40*
|
|
|
S-4
|
|
333-219101
|
|
10.49
|
|
June 30, 2017
|
|
|
10.41*
|
|
|
S-4
|
|
333-219101
|
|
10.50
|
|
June 30, 2017
|
|
|
10.42*
|
|
|
8-K
|
|
001-37397
|
|
10.2
|
|
June 18, 2018
|
|
|
10.43*
|
|
|
8-K
|
|
001-37397
|
|
10.3
|
|
June 18, 2018
|
|
|
10.44 +
|
|
|
|
|
|
|
|
|
|
|
|
10.45*
|
|
|
8-K
|
|
001-37397
|
|
10.1
|
|
June 8, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
101.INS +
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
101.SCH +
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
|
|
|
|
|
|
101.CAL +
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
|
|
|
|
|
|
101.DEF +
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
|
|
|
|
|
|
101.LAB +
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
|
|
|
|
|
|
101.PRE +
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
|
|
|
|
|
|
|
|
RIMINI STREET, INC.
|
|
|
|
|
|
|
Date: March 14, 2019
|
By:
|
/s/ Seth A. Ravin
|
|
|
|
Seth A. Ravin
|
|
|
|
Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
|
|
Date: March 14, 2019
|
By:
|
/s/ Seth A. Ravin
|
|
|
|
Seth A. Ravin
|
|
|
|
Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
|
|
|
|
|
|
Date: March 14, 2019
|
By:
|
/s/ Thomas B. Sabol
|
|
|
|
Thomas B. Sabol
|
|
|
|
Senior Vice President and Chief Financial Officer
(Principal Financial Officer/Principal Accounting Officer)
|
|
|
|
|
|
Date: March 14, 2019
|
By:
|
/s/ Jack L. Acosta
|
|
|
|
Jack L. Acosta
|
|
|
|
Director
|
|
|
|
|
|
Date: March 14, 2019
|
By:
|
/s/ Thomas Ashburn
|
|
|
|
Thomas Ashburn
|
|
|
|
Director
|
|
|
|
|
|
Date: March 14, 2019
|
By:
|
/s/ Antonio Bonchristiano
|
|
|
|
Antonio Bonchristiano
|
|
|
|
Director
|
|
|
|
|
|
Date: March 14, 2019
|
By:
|
/s/ Steve Capelli
|
|
|
|
Steve Capelli
|
|
|
|
Director
|
|
|
|
|
|
Date: March 14, 2019
|
By:
|
/s/ Andrew Fleiss
|
|
|
|
Andrew Fleiss
|
|
|
|
Director
|
|
|
|
|
|
Date: March 14, 2019
|
By:
|
/s/ Robin Murray
|
|
|
|
Robin Murray
|
|
|
|
Director
|
|
|
|
|
|
Date: March 14, 2019
|
By:
|
/s/ Margaret (Peggy) Taylor
|
|
|
|
Margaret (Peggy) Taylor
|
|
|
|
Director
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|